Enrichment analysis report,,,,,,,,,
Enrichment by Pathway Maps,,,,,up_genes_070120_genelist,,,,
#,Maps,Total,pValue,Min FDR,p-value,FDR,In Data,"Network Objects from
Active Data",
1,G protein-coupled receptors signaling in lung cancer,76,1.430E-06,1.578E-03,1.430E-06,1.578E-03,12,"STAT3, VIP receptor 1, Galpha(i)-specific peptide GPCRs, GRP-R, Amphiregulin, CCR5, VIP receptor 2, Galpha(q)-specific peptide GPCRs, SSTR2, IL8RA, PGE2R3, IL8RB",
2,Immune response_IL-4-responsive genes in type 2 immunity,70,2.696E-05,1.341E-02,2.696E-05,1.341E-02,10,"STAT3, IL-19, GATA-3, IGHG3, IL13RA2, AID, CCL17, IGHG4, TFF3, Mucin 5AC",
3,TMPRSS2-ERG fusion in Prostate Cancer,46,4.070E-05,1.341E-02,4.070E-05,1.341E-02,8,"Androgen receptor, PEP-19, YB-1, DSCAM, IGSF5 (JAM4), ERG, TAL1, Kallikrein 3 (PSA)",
4,Th2-cytokines induced expression of Mucin 5AC and maintenance of mucous cell phenotype in normal airway epithelium,35,4.861E-05,1.341E-02,4.861E-05,1.341E-02,7,"TITF1, p38alpha (MAPK14), IL13RA2, SP-A, HAG-2, Mucin 5AC, PDEF",
5,Breast cancer (general schema),41,1.403E-04,3.096E-02,1.403E-04,3.096E-02,7,"Androgen receptor, ESR1 (membrane), ESR1 (nuclear), PR (membrane), GHR, Prolactin receptor, PR (nuclear)",
6,Development_FGF and BMP signaling in early embryonic hepatogenesis,31,2.069E-04,3.803E-02,2.069E-04,3.803E-02,6,"Albumin, LRH1, HNF3-alpha, Transthyretin, FGFR4, FGFR1",
7,Development_FGF2 signaling during embryonic stem cell differentiation,34,3.516E-04,5.541E-02,3.516E-04,5.541E-02,6,"TITF1, Albumin, SOX2, FGF10, FGFR1, SOX3",
8,Development_Signaling pathways in embryonic hepatocyte maturation,51,5.661E-04,7.439E-02,5.661E-04,7.439E-02,7,"STAT3, TAT, CPSM, LRH1, Epo, PXR, C/EBPalpha",
9,Putative pathways of hormone action in neurofibromatosis type 1,25,6.070E-04,7.439E-02,6.070E-04,7.439E-02,5,"ESR1 (membrane), ESR1 (nuclear), EGR3, GHR, PR (nuclear)",
10,Dysregulation of direct glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes  ,53,7.179E-04,7.636E-02,7.179E-04,7.636E-02,7,"MaxiK alpha subunit, CACNA1H, SUR1, Kir6.2, PC2, Kv3.1, CACNA1D",
11,Th2-cytokines-induced mucous metaplasia in asthma,40,8.692E-04,7.636E-02,8.692E-04,7.636E-02,6,"TITF1, SP-A, PGE2R3, HAG-2, Mucin 5AC, PDEF",
12,Development_FGF signaling in pancreatic and hepatic differentiation of embryonic stem cells,40,8.692E-04,7.636E-02,8.692E-04,7.636E-02,6,"FGF4, Albumin, Alpha 1-antitrypsin, FGFR4, FGF10, FGFR1",
13,c-Myc in multiple myeloma,16,9.000E-04,7.636E-02,9.000E-04,7.636E-02,4,"STAT3, YB-1, p38 MAPK, C/EBPalpha",
14,Development_Muscle progenitor cell migration in hypaxial myogenesis,41,9.942E-04,7.833E-02,9.942E-04,7.833E-02,6,"PAX3, FGF4, FGFR4, FGFR1, MYOG, MYOD",
15,Role of tumor-infiltrating B cells in anti-tumor immunity,91,1.123E-03,8.258E-02,1.123E-03,8.258E-02,9,"STAT3, MHC class II, AID, PASD1, CTAG2, XAGE1, SOX2, GAGE2, MAGE-1 antigen",
16,Development_Transcription factors in segregation of hepatocytic lineage,30,1.449E-03,9.987E-02,1.449E-03,9.987E-02,5,"Albumin, CPSM, Alpha 1-antitrypsin, FGF10, C/EBPalpha",
17,Regulation of relaxation of airway smooth muscle cells,45,1.637E-03,1.062E-01,1.637E-03,1.062E-01,6,"VIP receptor 1, VIP receptor 2, Adenylate cyclase type IV, Adenylate cyclase type II, PGE2R3, MLCK",
18,Development_Schema: FGF signaling in embryonic stem cell self-renewal and differentiation,47,2.057E-03,1.261E-01,2.057E-03,1.261E-01,6,"TITF1, FGF4, Albumin, SOX2, TAL1, FGF10",
19,Development_G-CSF signaling,49,2.555E-03,1.483E-01,2.555E-03,1.483E-01,6,"STAT3, Hck, G-CSF, p38 MAPK, Bcl-2, IL8RB",
20,Action of lithium on synaptic transmission and autophagy,35,2.938E-03,1.620E-01,2.938E-03,1.620E-01,5,"PP2A regulatory, Adenylate cyclase type V, Adenylate cyclase type II, P2X2, Adenylate cyclase",
21,Regulation of Adenylate cyclase and IMPA1 by lithium in major depressive disorder,22,3.161E-03,1.660E-01,3.161E-03,1.660E-01,4,"Adenylate cyclase type II, Alpha-2A adrenergic receptor, P2X2, Adenylate cyclase",
22,PR action in breast cancer: stimulation of cell growth and proliferation,36,3.333E-03,1.671E-01,3.333E-03,1.671E-01,5,"STAT3, ESR1 (membrane), ESR1 (nuclear), PR (membrane), PR (nuclear)",
23,Development_Early embryonal hypaxial myogenesis,37,3.766E-03,1.806E-01,3.766E-03,1.806E-01,5,"PAX3, FGFR4, Adenylate cyclase, MYOG, MYOD",
24,Cell cycle progression in Prostate Cancer,39,4.748E-03,1.917E-01,4.748E-03,1.917E-01,5,"STAT3, Androgen receptor, Rb protein, p38 MAPK, Prolactin receptor",
25,Immune response_TSLP signalling,39,4.748E-03,1.917E-01,4.748E-03,1.917E-01,5,"STAT3, CISH, CCL17, p38 MAPK, Bcl-2",
26,FGF2 signaling in melanoma,39,4.748E-03,1.917E-01,4.748E-03,1.917E-01,5,"STAT3, PAX3, FGFR4, p38 MAPK, FGFR1",
27,Autocrine Somatotropin signaling in breast cancer,39,4.748E-03,1.917E-01,4.748E-03,1.917E-01,5,"p38alpha (MAPK14), CISH, TFF3, Bcl-2, GHR",
28,Immune response_IL-5 signaling via JAK/STAT,56,5.024E-03,1.917E-01,5.024E-03,1.917E-01,6,"STAT3, AID, Amphiregulin, CISH, XBP1, Bcl-2",
29,Neurophysiological process_Regulation of intrinsic membrane properties and excitability of cortical pyramidal neurons,74,5.040E-03,1.917E-01,5.040E-03,1.917E-01,7,"MaxiK alpha subunit, SK2, Alpha-2A adrenergic receptor, NAV1.9, Kir2.2, Adenylate cyclase, CACNA1D",
30,Nociception_Nociceptin receptor signaling,76,5.835E-03,2.059E-01,5.835E-03,2.059E-01,7,"STAT3, TY3H, Adenylate cyclase type II, Kir3.1, AP-2, p38 MAPK, Adenylate cyclase",
31,Development_Regulation of lung epithelial progenitor cell differentiation,41,5.901E-03,2.059E-01,5.901E-03,2.059E-01,5,"STAT3, TITF1, p38alpha (MAPK14), SP-A, FGF10",
32,Putative role of Estrogen receptor and Androgen receptor signaling in progression of lung cancer,58,5.973E-03,2.059E-01,5.973E-03,2.059E-01,6,"Androgen receptor, ESR1 (membrane), ESR1 (nuclear), p38 MAPK, Bcl-2, Kallikrein 3 (PSA)",
33,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,42,6.545E-03,2.101E-01,6.545E-03,2.101E-01,5,"OATP-C, CYP2A6, OATP-A, S14 protein, PXR",
34,Glomerular filtration and renal reabsorption of bile acids / Rodent version,27,6.780E-03,2.101E-01,6.780E-03,2.101E-01,4,"ABCC11, OATP-C, SLC22A8, OATP-A",
35,Th2-cytokines-induced expression of mucins in asthma ,43,7.238E-03,2.101E-01,7.238E-03,2.101E-01,5,"STAT3, p38alpha (MAPK14), IL13RA2, Mucin 2, Mucin 5AC",
36,Development_WNT/Beta-catenin signaling in embryogenesis,43,7.238E-03,2.101E-01,7.238E-03,2.101E-01,5,"Mesogenin 1, PAX3, LHX8, SOX2, LRH1",
37,Signal transduction_Modulation of calcium and potassium channels by Adenosine A1 receptor,43,7.238E-03,2.101E-01,7.238E-03,2.101E-01,5,"MaxiK alpha subunit, SK2, SUR1, Kir6.2, Adenylate cyclase",
38,FGF signaling in Prostate Cancer,43,7.238E-03,2.101E-01,7.238E-03,2.101E-01,5,"STAT3, Androgen receptor, FGFR4, FGF10, FGFR1",
39,Neurophysiological process_Bitter taste signaling,28,7.736E-03,2.188E-01,7.736E-03,2.188E-01,4,"T2R taste receptors, T2R47, P2X2, Gustducin",
40,Tinnitus-associated changes in auditory pathway ,82,8.784E-03,2.422E-01,8.784E-03,2.422E-01,7,"mGluR4A, GRIK4, GABA-A receptor gamma-2 subunit, GluR5, GluR3, GLRA, GABA-A receptor delta subunit",
41,Development_Role of BMP signaling in embryonic stem cell neural differentiation,30,9.903E-03,2.540E-01,9.903E-03,2.540E-01,4,"Chordin, BMP7, SOX2, SOX3",
42,Development_G-CSF-induced myeloid differentiation,30,9.903E-03,2.540E-01,9.903E-03,2.540E-01,4,"STAT3, Rb protein, G-CSF, C/EBPalpha",
43,Regulation of IGF family activity in colorectal cancer,30,9.903E-03,2.540E-01,9.903E-03,2.540E-01,4,"CEACAM5, IBP2, IBP5, IBP",
44,Neurophysiological process_Dopamine D2 receptor signaling in CNS,47,1.052E-02,2.637E-01,1.052E-02,2.637E-01,5,"TY3H, Adenylate cyclase type IV, Adenylate cyclase type V, Adenylate cyclase type II, Kir3.1",
45,Regulation of lipid metabolism_FXR-dependent negative-feedback regulation of bile acids concentration,31,1.112E-02,2.677E-01,1.112E-02,2.677E-01,4,"LRH1, HNF3-alpha, PXR, UGT2B4",
46,Signal transduction_Adenosine A3 receptor signaling pathway,48,1.147E-02,2.677E-01,1.147E-02,2.677E-01,5,"STAT3, Rho GTPase, p38 MAPK, Adenylate cyclase, Bcl-2",
47,Development_FGF10 in development of subcutaneous white adipose tissue in embryogenesis,17,1.160E-02,2.677E-01,1.160E-02,2.677E-01,3,"A-FABP, FGF10, C/EBPalpha",
48,Ligand-independent activation of Androgen receptor in Prostate Cancer,67,1.191E-02,2.677E-01,1.191E-02,2.677E-01,6,"STAT3, Androgen receptor, PP2A regulatory, FGFR1, Kallikrein 3 (PSA), Prolactin receptor",
49,Putative pathways for stimulation of fat cell differentiation by Bisphenol A,32,1.243E-02,2.677E-01,1.243E-02,2.677E-01,4,"Androgen receptor, A-FABP, ESR1 (nuclear), C/EBPalpha",
50,Androstenedione and testosterone biosynthesis and metabolism p.2,32,1.243E-02,2.677E-01,1.243E-02,2.677E-01,4,"UGT2B28, AKR1C4, UGT2B17, UGT2B15",
51,Neutrophil-derived granule proteins and cytokines in asthma,49,1.249E-02,2.677E-01,1.249E-02,2.677E-01,5,"Hck, CCL17, Tryptase, IL8RA, IL8RB",
52,Androgen receptor activation and downstream signaling in Prostate cancer,110,1.328E-02,2.677E-01,1.328E-02,2.677E-01,8,"STAT3, Androgen receptor, Rb protein, PSCA, HNF3-alpha, FGFR1, Kallikrein 3 (PSA), Clusterin",
53,Neurophysiological process_Leptin signaling in neurons,50,1.356E-02,2.677E-01,1.356E-02,2.677E-01,5,"STAT3, TY3H, IRS-4, MaxiK alpha subunit, Kir6.2",
54,Protein folding and maturation_Posttranslational processing of neuroendocrine peptides,50,1.356E-02,2.677E-01,1.356E-02,2.677E-01,5,"CCK8, PC2, CCK8-Gly, Pro-CCK, CCK8-GlyArgArg",
55,Signal transduction_CXCR4 signaling via second messengers and JAK/STAT,50,1.356E-02,2.677E-01,1.356E-02,2.677E-01,5,"STAT3, MaxiK alpha subunit, Adenylate cyclase, MLCK, Bcl-2",
56,Development_BMP signaling,33,1.383E-02,2.677E-01,1.383E-02,2.677E-01,4,"Chordin, BMP7, p38 MAPK, Tob1",
57,LRRK2 in neurons in Parkinson's disease,33,1.383E-02,2.677E-01,1.383E-02,2.677E-01,4,"Tau (MAPT), LRRK2, eEF1A2, eEF1A",
58,Immune response_IL-11 signaling via JAK/STAT,34,1.533E-02,2.873E-01,1.533E-02,2.873E-01,4,"STAT3, A-FABP, Bcl-2, MYOD",
59,Anti-apoptotic pathways in endoplasmic reticulum stress response in multiple myeloma,19,1.586E-02,2.873E-01,1.586E-02,2.873E-01,3,"XBP1, p38 MAPK, Bcl-2",
60,Development_FGF-family signaling,52,1.589E-02,2.873E-01,1.589E-02,2.873E-01,5,"FGF4, FGFR4, p38 MAPK, FGF10, FGFR1",
61,Signal transduction_Adenosine A2A receptor signaling pathway,52,1.589E-02,2.873E-01,1.589E-02,2.873E-01,5,"Kir6.2, ENPP1, SFK, p38 MAPK, Adenylate cyclase",
62,"Immune response_IL-3 signaling via JAK/STAT, p38, JNK and NF-kB",93,1.682E-02,2.874E-01,1.682E-02,2.874E-01,7,"STAT3, TCR gamma locus, MHC class II, CISH, XBP1, p38 MAPK, Bcl-2",
63,Pro-oncogenic action of Androgen receptor in breast cancer,35,1.693E-02,2.874E-01,1.693E-02,2.874E-01,4,"Androgen receptor, PIP, HNF3-alpha, Kallikrein 3 (PSA)",
64,Development_Extraembryonic differentiation of embryonic stem cells,35,1.693E-02,2.874E-01,1.693E-02,2.874E-01,4,"GATA-3, BMP7, SOX2, HNF3-alpha",
65,Neurophysiological process_Thyroliberin in cell hyperpolarization and excitability,35,1.693E-02,2.874E-01,1.693E-02,2.874E-01,4,"MaxiK alpha subunit, Thyroliberin, KCNH7, Kir3.1",
66,Regulation of AKT(PKB)/ GSK3 beta cascade in bipolar disorder,54,1.847E-02,2.895E-01,1.847E-02,2.895E-01,5,"ESR1 (membrane), RET, Epo, GFRalpha1, FGFR1",
67,Development_Differentiation of white adipocytes ,54,1.847E-02,2.895E-01,1.847E-02,2.895E-01,5,"p38alpha (MAPK14), A-FABP, Rb protein, Perilipin, C/EBPalpha",
68,Th17 cytokines in COPD,36,1.863E-02,2.895E-01,1.863E-02,2.895E-01,4,"STAT3, MHC class II, p38 MAPK, Mucin 5AC",
69,Immune response_IL-22 signaling pathway,36,1.863E-02,2.895E-01,1.863E-02,2.895E-01,4,"STAT3, MHC class II, p38 MAPK, Bcl-2",
70,Nitrogen metabolism,36,1.863E-02,2.895E-01,1.863E-02,2.895E-01,4,"Carbonic anhydrase XII, CPSM, Carbonic anhydrase IV, DHE4",
71,Development_EPO-induced Jak-STAT pathway,36,1.863E-02,2.895E-01,1.863E-02,2.895E-01,4,"STAT3, CISH, Epo, Bcl-2",
72,Noise-induced hair cell death and spiral ganglion neuron degeneration,96,1.970E-02,3.018E-01,1.970E-02,3.018E-01,7,"STAT3, p38alpha (MAPK14), Rb protein, CACNA1I, RET, GFRalpha1, CACNA1D",
73,Role of ZNF202 in regulation of expression of genes involved in atherosclerosis,21,2.087E-02,3.154E-01,2.087E-02,3.154E-01,3,"ABCG1, IA-1, HDL proteins",
74,Development_WNT/Beta-catenin and NOTCH in induction of osteogenesis,40,2.647E-02,3.722E-01,2.647E-02,3.722E-01,4,"A-FABP, Adiponectin, Bone sialoprotein, C/EBPalpha",
75,Cell adhesion_IL-8 family-dependent cell migration and adhesion,40,2.647E-02,3.722E-01,2.647E-02,3.722E-01,4,"EBP50, IL8RA, p38 MAPK, IL8RB",
76,Androstenedione and testosterone biosynthesis and metabolism p.3,40,2.647E-02,3.722E-01,2.647E-02,3.722E-01,4,"UGT2B28, AKR1C4, UGT2B17, UGT2B4",
77,Inhibition of Vitamin D pathway in Prostate Cancer,40,2.647E-02,3.722E-01,2.647E-02,3.722E-01,4,"Androgen receptor, p38alpha (MAPK14), Rb protein, Bcl-2",
78,Cytoskeleton remodeling_ESR1 action on cytoskeleton remodeling and cell migration,23,2.666E-02,3.722E-01,2.666E-02,3.722E-01,3,"ESR1 (membrane), EBP50, ESR1 (nuclear)",
79,Development_Thrombopoietin signaling via JAK-STAT pathway,23,2.666E-02,3.722E-01,2.666E-02,3.722E-01,3,"STAT3, CISH, ERG",
80,Maturation and migration of dendritic cells in skin sensitization,41,2.869E-02,3.956E-01,2.869E-02,3.956E-01,4,"MHC class II alpha chain, MHC class II, MHC class II beta chain, p38 MAPK",
81,Immune response_IL-9 signaling pathway,61,2.961E-02,4.012E-01,2.961E-02,4.012E-01,5,"STAT3, CISH, Mucin 2, Mucin 5AC, Bcl-2",
82,Prolactin/ JAK2 signaling in breast cancer,24,2.984E-02,4.012E-01,2.984E-02,4.012E-01,3,"STAT3, CISH, Prolactin receptor",
83,Estradiol metabolism,42,3.103E-02,4.012E-01,3.103E-02,4.012E-01,4,"UGT2B28, SULT1A1, UGT2B11, UGT2B17",
84,Signal transduction_Adenosine A1 receptor signaling pathway,62,3.148E-02,4.012E-01,3.148E-02,4.012E-01,5,"STAT3, GLRA3, SFK, p38 MAPK, Adenylate cyclase",
85,"Immune response_IL-4-induced regulators of cell growth, survival, differentiation and metabolism",62,3.148E-02,4.012E-01,3.148E-02,4.012E-01,5,"STAT3, GATA-3, A-FABP, CISH, Bcl-2",
86,Immune response_IL-10 signaling pathway,62,3.148E-02,4.012E-01,3.148E-02,4.012E-01,5,"STAT3, Fc gamma RII beta, MHC class II, G-CSF, Bcl-2",
87,Role of Nicotine-induced Leptin resistance in hypothalamus in development of obesity,25,3.321E-02,4.012E-01,3.321E-02,4.012E-01,3,"STAT3, Thyroliberin, CART",
88,Defective macrophage-mediated bacterial phagocytosis in COPD,25,3.321E-02,4.012E-01,3.321E-02,4.012E-01,3,"Tubulin alpha, RhoB, SP-D",
89,Apoptosis and survival_CXCR3-B signaling,63,3.343E-02,4.012E-01,3.343E-02,4.012E-01,5,"STAT3, GATA-3, p38 MAPK, Adenylate cyclase, Bcl-2",
90,Neuroprotective action of lithium,63,3.343E-02,4.012E-01,3.343E-02,4.012E-01,5,"p38alpha (MAPK14), Tau (MAPT), P2X2, p38 MAPK, Bcl-2",
91,"POMC, alpha-MSH and AGRP in regulation of food intake and energy expenditure in obesity in hypothalamus",43,3.347E-02,4.012E-01,3.347E-02,4.012E-01,4,"Adenylate cyclase type IV, Adenylate cyclase type II, Thyroliberin, PC2",
92,Regulation of proinflammatory cytokine production by Th2 cells in asthma,43,3.347E-02,4.012E-01,3.347E-02,4.012E-01,4,"p38alpha (MAPK14), IL-19, GATA-3, MHC class II",
93,Immune response_IL-13 signaling via JAK-STAT,44,3.601E-02,4.225E-01,3.601E-02,4.225E-01,4,"STAT3, IL13RA2, CCL17, IGHG4",
94,Neurophysiological process_Melatonin signaling,44,3.601E-02,4.225E-01,3.601E-02,4.225E-01,4,"MaxiK alpha subunit, Kir3.1, HSD17B1, Adenylate cyclase",
95,Role of fibroblasts and keratinocytes in the elicitation phase of allergic contact dermatitis,26,3.677E-02,4.225E-01,3.677E-02,4.225E-01,3,"CCR5, IL8RA, IL8RB",
96,Pioglitazone and Rosiglitazone in treatment of type 2 diabetes and metabolic syndrome X,26,3.677E-02,4.225E-01,3.677E-02,4.225E-01,3,"A-FABP, Adiponectin, ABCG1",
97,Dysregulation of germinal center response in SLE,65,3.754E-02,4.232E-01,3.754E-02,4.232E-01,5,"STAT3, Fc gamma RII beta, AID, ESR1 (nuclear), RGS16",
98,"Mechanism of Pioglitazone/Glimepiride and Rosiglitazone/Glimepiride cooperative action in Diabetes mellitus, Type 2",11,3.760E-02,4.232E-01,3.760E-02,4.232E-01,2,"SUR1, Kir6.2",
99,Nociception_Expression and role of Nociceptin in immune system,46,4.144E-02,4.617E-01,4.144E-02,4.617E-01,4,"STAT3, ESR1 (nuclear), CaMK II beta, p38 MAPK",
100,Inflammatory mechanisms of pancreatic cancerogenesis,67,4.195E-02,4.627E-01,4.195E-02,4.627E-01,5,"STAT3, C/EBP, IL8RA, Bcl-2, IL8RB",
101,Neurophysiological process_PGE2-induced pain processing,47,4.432E-02,4.715E-01,4.432E-02,4.715E-01,4,"GLRA3, PGE2R3, GLRA, Adenylate cyclase",
102,Role of Diethylhexyl Phthalate and Tributyltin in fat cell differentiation ,28,4.446E-02,4.715E-01,4.446E-02,4.715E-01,3,"A-FABP, Adiponectin, C/EBPalpha",
103,IL-17 and IL-17F-induced inflammatory signaling in normal and asthmatic airway epithelium,28,4.446E-02,4.715E-01,4.446E-02,4.715E-01,3,"IL-19, G-CSF, p38 MAPK",
104,Th1 and Th17 cells in an autoimmune mechanism of emphysema formation in smokers,28,4.446E-02,4.715E-01,4.446E-02,4.715E-01,3,"MHC class II, CCR5, Alpha 1-antitrypsin",
105,Oxidative stress_Role of IL-8 signaling pathway in respiratory burst,48,4.730E-02,4.940E-01,4.730E-02,4.940E-01,4,"IL8RA, p38 MAPK, PREX1, IL8RB",
106,"Development_The role of GDNF ligand family/ RET receptor in cell survival, growth and proliferation",92,4.748E-02,4.940E-01,4.748E-02,4.940E-01,6,"STAT3, p38alpha (MAPK14), RET, GFRalpha2, GFRalpha1, Bcl-2",
107,Histone deacetylases in Prostate Cancer,29,4.857E-02,4.961E-01,4.857E-02,4.961E-01,3,"Androgen receptor, Tubulin alpha, Kallikrein 3 (PSA)",
108,Neurophysiological process _Visual perception,29,4.857E-02,4.961E-01,4.857E-02,4.961E-01,3,"SLC24A2, Rhodopsin, Guanylate cyclase 2D (RETGC1)",
109,Mechanisms of drug resistance in multiple myeloma,49,5.040E-02,5.010E-01,5.040E-02,5.010E-01,4,"STAT3, IL8RA, Bcl-2, IL8RB",
110,Development_Role of nicotinamide in G-CSF-induced granulopoiesis,13,5.137E-02,5.010E-01,5.137E-02,5.010E-01,2,"G-CSF, C/EBPalpha",
111,Development_EGFR signaling pathway,71,5.167E-02,5.010E-01,5.167E-02,5.010E-01,5,"STAT3, p38alpha (MAPK14), MKP-2, Amphiregulin, p38 MAPK",
112,Inhibition of neutrophil migration by proresolving lipid mediators in COPD,71,5.167E-02,5.010E-01,5.167E-02,5.010E-01,5,"CCR5, IL8RA, p38 MAPK, PREX1, IL8RB",
113,Immune response_Antigen presentation by MHC class II,118,5.177E-02,5.010E-01,5.177E-02,5.010E-01,7,"MHC class II alpha chain, Fc gamma RII beta, MHC class II, MHC class II beta chain, RhoB, p38 MAPK, Bcl-2",
114,Development_WNT/Beta-catenin signaling in organogenesis,30,5.287E-02,5.010E-01,5.287E-02,5.010E-01,3,"FoxN1, MEPE, FGF10",
115,Retinoic acid maintains mucocilliary differentiation and mucins expression in normal and asthmatic airway epithelium,30,5.287E-02,5.010E-01,5.287E-02,5.010E-01,3,"SPRR1A, Mucin 2, Mucin 5AC",
116,Neurophysiological process_Mu-type opioid receptor-mediated analgesia,30,5.287E-02,5.010E-01,5.287E-02,5.010E-01,3,"Adenylate cyclase type IV, Adenylate cyclase type V, Adenylate cyclase type II",
117,Development_GM-CSF signaling,50,5.360E-02,5.010E-01,5.360E-02,5.010E-01,4,"STAT3, Hck, CISH, Bcl-2",
118,Apoptosis and survival_HTR1A signaling,50,5.360E-02,5.010E-01,5.360E-02,5.010E-01,4,"STAT3, PP2A regulatory, Adenylate cyclase, Bcl-2",
119,Role of epigenetic alterations in proliferation and differentiation of SCLC cells,72,5.429E-02,5.032E-01,5.429E-02,5.032E-01,5,"PAX3, Rb protein, CCDC140, YAP1 (YAp65), C/EBPalpha",
120,Inflammatory factors-induced expression of mucins in normal and asthmatic epithelium,51,5.691E-02,5.184E-01,5.691E-02,5.184E-01,4,"IL8RA, Mucin 2, Mucin 5AC, IL8RB",
121,Signal transduction_PKA signaling,51,5.691E-02,5.184E-01,5.691E-02,5.184E-01,4,"Androgen receptor, PP2A regulatory, PKI, Adenylate cyclase",
122,Development_Embryonal epaxial myogenesis,31,5.734E-02,5.184E-01,5.734E-02,5.184E-01,3,"PAX3, MYOG, MYOD",
123,Macrophage-induced immunosuppression in the tumor microenvironment,97,5.862E-02,5.257E-01,5.862E-02,5.257E-01,6,"STAT3, ALOX15B, CCL17, CCR8, p38 MAPK, CAT-2",
124,Development_Transcription regulation of granulocyte development,32,6.199E-02,5.394E-01,6.199E-02,5.394E-01,3,"STAT3, G-CSF, C/EBPalpha",
125,Role of IL-6 in obesity and type 2 diabetes in adipocytes,32,6.199E-02,5.394E-01,6.199E-02,5.394E-01,3,"STAT3, Adiponectin, Perilipin",
126,"Development_NCAM1-mediated neurite outgrowth, synapse assembly and neuronal survival",75,6.260E-02,5.394E-01,6.260E-02,5.394E-01,5,"Tau (MAPT), CACNA1H, DNAI1, GFRalpha1, FGFR1",
127,"Development_Insulin, IGF-1 and TNF-alpha in brown adipocyte differentiation",53,6.385E-02,5.394E-01,6.385E-02,5.394E-01,4,"A-FABP, Adiponectin, Perilipin, C/EBPalpha",
128,IL-6 signaling in breast cancer cells,53,6.385E-02,5.394E-01,6.385E-02,5.394E-01,4,"STAT3, ESR1 (nuclear), HSD17B1, Bcl-2",
129,Immune response_Alternative complement pathway,53,6.385E-02,5.394E-01,6.385E-02,5.394E-01,4,"CRIg, C5L2, FHR-5, Clusterin",
130,Cell cycle_Influence of Ras and Rho proteins on G1/S Transition,53,6.385E-02,5.394E-01,6.385E-02,5.394E-01,4,"STAT3, Rb protein, Tob1, MLCK",
131,Deficient alpha-MSH signaling in melanoma,33,6.680E-02,5.394E-01,6.680E-02,5.394E-01,3,"p38alpha (MAPK14), Rb protein, p38 MAPK",
132,Role of GSK3 beta in cardioprotection against myocardial infarction,33,6.680E-02,5.394E-01,6.680E-02,5.394E-01,3,"Kir6.1, Kir6.2, Epo",
133,Prolactin signaling in Prostate Cancer,33,6.680E-02,5.394E-01,6.680E-02,5.394E-01,3,"Androgen receptor, PIP, Prolactin receptor",
134,Cytoskeleton remodeling_Thyroliberin in cytoskeleton remodeling,33,6.680E-02,5.394E-01,6.680E-02,5.394E-01,3,"Tau (MAPT), Thyroliberin, Adenylate cyclase",
135,Development_Self-renewal and pluripotency maintenance of human embryonic stem cells,33,6.680E-02,5.394E-01,6.680E-02,5.394E-01,3,"Albumin, SOX2, CG alpha",
136,Muscle contraction_Role of kappa-type opioid receptor in heart,33,6.680E-02,5.394E-01,6.680E-02,5.394E-01,3,"Kir6.1, Kir6.2, Adenylate cyclase",
137,Dysregulation of indirect glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes ,54,6.748E-02,5.394E-01,6.748E-02,5.394E-01,4,"SUR1, ZnT-8, Kir6.2, PC2",
138,Th17 cells in CF,54,6.748E-02,5.394E-01,6.748E-02,5.394E-01,4,"STAT3, MHC class II, G-CSF, p38 MAPK",
139,Cell adhesion_Integrin inside-out signaling in neutrophils,77,6.852E-02,5.437E-01,6.852E-02,5.437E-01,5,"Hck, IL8RA, p38 MAPK, PREX1, IL8RB",
140,Cytoskeleton remodeling_Substance P mediated membrane blebbing,16,7.476E-02,5.812E-01,7.476E-02,5.812E-01,2,"Tubulin alpha, MLCK",
141,MAPK-mediated proliferation of normal and asthmatic smooth muscle cells,56,7.506E-02,5.812E-01,7.506E-02,5.812E-01,4,"p38alpha (MAPK14), Amphiregulin, Rb protein, FGFR1",
142,Development_YAP/TAZ-mediated co-regulation of transcription,56,7.506E-02,5.812E-01,7.506E-02,5.812E-01,4,"GATA-3, PAX3, SOX2, YAP1 (YAp65)",
143,Interleukins-induced inflammatory response in asthmatic airway fibroblasts,35,7.693E-02,5.812E-01,7.693E-02,5.812E-01,3,"p38alpha (MAPK14), G-CSF, p38 MAPK",
144,Cell adhesion_Plasmin signaling,35,7.693E-02,5.812E-01,7.693E-02,5.812E-01,3,"LEKTI, p38 MAPK, FGFR1",
145,Transcription_Role of the non-genomic action of Retinoic acid and phosphorylation of Retinoic acid receptors in the initiation of transcription,35,7.693E-02,5.812E-01,7.693E-02,5.812E-01,3,"p38alpha (MAPK14), Transthyretin, p38 MAPK",
146,Development_Schema: Adult neuron differentiation in the Subventricular and Subgranular Zones,35,7.693E-02,5.812E-01,7.693E-02,5.812E-01,3,"TY3H, Doublecortin, SOX2",
147,Skeletal muscle atrophy in COPD,57,7.900E-02,5.928E-01,7.900E-02,5.928E-01,4,"p38alpha (MAPK14), p38 MAPK, MYOG, MYOD",
148,Cytoskeleton remodeling_Keratin filaments,36,8.222E-02,5.958E-01,8.222E-02,5.958E-01,3,"Keratin 1, Tubulin alpha, Keratin 2",
149,Beta-catenin-dependent transcription regulation in colorectal cancer,36,8.222E-02,5.958E-01,8.222E-02,5.958E-01,3,"Mucin 2, NRCAM, YAP1 (YAp65)",
150,Development_Beta adrenergic receptors in brown adipocyte differentiation,36,8.222E-02,5.958E-01,8.222E-02,5.958E-01,3,"A-FABP, p38 MAPK, Adenylate cyclase",
151,Role of IL-8 in melanoma,36,8.222E-02,5.958E-01,8.222E-02,5.958E-01,3,"IL8RA, p38 MAPK, IL8RB",
152,Immune response_IL-12-induced IFN-gamma production,36,8.222E-02,5.958E-01,8.222E-02,5.958E-01,3,"STAT3, p38alpha (MAPK14), GADD45 gamma",
153,Signal transduction_Leptin signaling in non-neuronal cells,58,8.305E-02,5.958E-01,8.305E-02,5.958E-01,4,"STAT3, SUR1, Kir6.2, Bcl-2",
154,Involvement of VEGF signaling in the progression of lung cancer,17,8.318E-02,5.958E-01,8.318E-02,5.958E-01,2,"p38 MAPK, C/EBPalpha",
155,Cholehepatic circulation of bile acids / Rodent version,37,8.768E-02,6.082E-01,8.768E-02,6.082E-01,3,"ABCC11, OATP-C, OATP-A",
156,IL-6 signaling in colorectal cancer,37,8.768E-02,6.082E-01,8.768E-02,6.082E-01,3,"STAT3, TFF3, Clusterin",
157,Immune response_IL-7 signaling in T lymphocytes,37,8.768E-02,6.082E-01,8.768E-02,6.082E-01,3,"STAT3, TCR gamma locus, Bcl-2",
158,Development_Delta-type opioid receptor mediated cardioprotection,37,8.768E-02,6.082E-01,8.768E-02,6.082E-01,3,"STAT3, Kir6.1, Kir6.2",
159,Apoptosis and survival_Anti-apoptotic action of nuclear ESR1 and ESR2,37,8.768E-02,6.082E-01,8.768E-02,6.082E-01,3,"p38alpha (MAPK14), ESR1 (nuclear), Bcl-2",
160,Pro-oncogenic action of Estradiol/ Estrogen receptors in ovarian cancer,60,9.143E-02,6.161E-01,9.143E-02,6.161E-01,4,"STAT3, ESR1 (membrane), ESR1 (nuclear), TFF1",
161,FGF2 in multiple myeloma,18,9.188E-02,6.161E-01,9.188E-02,6.161E-01,2,"FGFR4, FGFR1",
162,Signal transduction_Cyclic AMP signaling,38,9.328E-02,6.161E-01,9.328E-02,6.161E-01,3,"Adenylate cyclase type IV, Adenylate cyclase type V, Adenylate cyclase type II",
163,Defective efferocytosis in COPD,38,9.328E-02,6.161E-01,9.328E-02,6.161E-01,3,"SP-A, SP-D, ELMO1",
164,Neutrophil chemotaxis in asthma,38,9.328E-02,6.161E-01,9.328E-02,6.161E-01,3,"IL8RA, Tissue kallikreins, IL8RB",
165,Impaired macrophage phagocytic function in asthma,38,9.328E-02,6.161E-01,9.328E-02,6.161E-01,3,"GSTM1, SP-A, SP-D",
166,Eosinophil-derived cytokines in airway remodeling in asthma,38,9.328E-02,6.161E-01,9.328E-02,6.161E-01,3,"Amphiregulin, MMP-17, p38 MAPK",
167,"Dysregulation of Adiponectin secretion from adipocytes in obesity, type 2 diabetes and metabolic syndrome X",38,9.328E-02,6.161E-01,9.328E-02,6.161E-01,3,"AP-2B, Adiponectin, C/EBPalpha",
168,"Immune response_Th17, Th22 and Th9 cell differentiation ",39,9.902E-02,6.283E-01,9.902E-02,6.283E-01,3,"STAT3, GATA-3, MHC class II",
169,Transport_Regulation of ATP-binding transporters by Retinoic acid and orphan nuclear receptor PXR,39,9.902E-02,6.283E-01,9.902E-02,6.283E-01,3,"OATP-C, ABCG1, PXR",
170,Signal transduction_Leptin signaling via JAK/STAT and MAPK cascade,39,9.902E-02,6.283E-01,9.902E-02,6.283E-01,3,"STAT3, Thyroliberin, CART",
171,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Rodent version,39,9.902E-02,6.283E-01,9.902E-02,6.283E-01,3,"OATP-A, S14 protein, PXR",
172,Regulation of CFTR activity (normal and CF),62,1.002E-01,6.283E-01,1.002E-01,6.283E-01,4,"PDZK1, EBP50, PP2A regulatory, Adenylate cyclase",
173,Role of IL-8 in colorectal cancer,19,1.008E-01,6.283E-01,1.008E-01,6.283E-01,2,"IL8RA, IL8RB",
174,Regulation of lipid metabolism_Regulation of acetyl-CoA carboxylase 2 activity in muscle,19,1.008E-01,6.283E-01,1.008E-01,6.283E-01,2,"MYOG, MYOD",
175,Brca1 and Brca2 in breast cancer,19,1.008E-01,6.283E-01,1.008E-01,6.283E-01,2,"ESR1 (membrane), ESR1 (nuclear)",
176,Development_Schema: Adult neurogenesis in the Subventricular Zone,19,1.008E-01,6.283E-01,1.008E-01,6.283E-01,2,"TY3H, Doublecortin",
177,Ethanol/Acetaldehyde-dependent stimulation of MMP-9 expression in HCC,19,1.008E-01,6.283E-01,1.008E-01,6.283E-01,2,"p38 MAPK, ADH7",
178,Neurophysiological process_Glucose-excited neurons of arcuate nucleus (rodent model),40,1.049E-01,6.323E-01,1.049E-01,6.323E-01,3,"SUR1, Kir6.2, CART",
179,Transcription_Role of heterochromatin protein 1 (HP1) family in transcriptional silencing,40,1.049E-01,6.323E-01,1.049E-01,6.323E-01,3,"Rb protein, MYOG, MYOD",
180,Reproduction_Progesterone-mediated oocyte maturation,40,1.049E-01,6.323E-01,1.049E-01,6.323E-01,3,"ESR1 (membrane), Adenylate cyclase, PR (membrane)",
181,IFN-gamma and Th2 cytokines-induced inflammatory signaling in normal and asthmatic airway epithelium,40,1.049E-01,6.323E-01,1.049E-01,6.323E-01,3,"IL13RA2, CCL17, p38 MAPK",
182,Enterohepatic circulation of bile acids / Rodent version,40,1.049E-01,6.323E-01,1.049E-01,6.323E-01,3,"ABCC11, OATP-C, OATP-A",
183,IL-6 signaling in Prostate Cancer,40,1.049E-01,6.323E-01,1.049E-01,6.323E-01,3,"STAT3, Androgen receptor, Kallikrein 3 (PSA)",
184,Mechanism of Maraviroc action in HIV Infections,4,1.093E-01,6.405E-01,1.093E-01,6.405E-01,1,CCR5,
185,MAPK-independent proliferation of normal and asthmatic smooth muscle cells,64,1.093E-01,6.405E-01,1.093E-01,6.405E-01,4,"STAT3, Rb protein, Tryptase, FGFR1",
186,Role of Langerin+ dermal dendritic cells in contact hypersensitivity,20,1.100E-01,6.405E-01,1.100E-01,6.405E-01,2,"STAT3, FLT3",
187,Neurophysiological process_Olfactory transduction,20,1.100E-01,6.405E-01,1.100E-01,6.405E-01,2,"ANO2, Olfactory receptor",
188,PR action in breast cancer: stimulation of metastasis,20,1.100E-01,6.405E-01,1.100E-01,6.405E-01,2,"PR (membrane), PR (nuclear)",
189,Development_TGF-beta-induction of EMT via ROS,20,1.100E-01,6.405E-01,1.100E-01,6.405E-01,2,"p38alpha (MAPK14), p38 MAPK",
190,Regulation of metabolism_Bile acids regulation of glucose and lipid metabolism via FXR,41,1.109E-01,6.405E-01,1.109E-01,6.405E-01,3,"HNF3-alpha, HNF3, F16P",
191,Stem cells_Inhibition of Hedgehog signaling in medulloblastoma stem cells,41,1.109E-01,6.405E-01,1.109E-01,6.405E-01,3,"FGF4, FGFR4, FGFR1",
192,Transcription_FXR-regulated cholesterol and bile acids cellular transport,42,1.171E-01,6.551E-01,1.171E-01,6.551E-01,3,"ABCG8, LRH1, PXR",
193,Inhibition of GTPase prenylation by statins in asthma and COPD,42,1.171E-01,6.551E-01,1.171E-01,6.551E-01,3,"RhoB, p38 MAPK, Mucin 5AC",
194,Transcription targets of Androgen receptor involved in Prostate Cancer,42,1.171E-01,6.551E-01,1.171E-01,6.551E-01,3,"Androgen receptor, Kallikrein 3 (PSA), Clusterin",
195,Development_TGF-beta family mediated differentiation of embryonic stem cells,42,1.171E-01,6.551E-01,1.171E-01,6.551E-01,3,"SOX2, Transthyretin, SOX3",
196,Stromal-epithelial interaction in Prostate Cancer,42,1.171E-01,6.551E-01,1.171E-01,6.551E-01,3,"Androgen receptor, FGF10, FGFR1",
197,CFTR-dependent regulation of ion channels in CF,42,1.171E-01,6.551E-01,1.171E-01,6.551E-01,3,"EBP50, YAP1 (YAp65), CLCA2",
198,Development_Schema: Osteogenic and adipogenic differentiation of mesenchymal stem cells,21,1.194E-01,6.551E-01,1.194E-01,6.551E-01,2,"Rb protein, BMP7",
199,HCV-dependent transcription regulation leading to HCC,21,1.194E-01,6.551E-01,1.194E-01,6.551E-01,2,"STAT3, Rb protein",
200,Development_Generation of pancreatic beta-cells from embryonic stem cells (early stages),21,1.194E-01,6.551E-01,1.194E-01,6.551E-01,2,"SOX2, FGF10",
201,Development_Role of G-CSF in hematopoietic stem cell mobilization,21,1.194E-01,6.551E-01,1.194E-01,6.551E-01,2,"STAT3, G-CSF",
202,Prostaglandins and leukotrienes-mediated induction of expression of mucins in normal and asthmatic epithelium ,43,1.233E-01,6.564E-01,1.233E-01,6.564E-01,3,"Mucin 2, Mucin 5AC, Adenylate cyclase",
203,HGF receptor (Met) and MSP receptor (RON) signaling pathways in SCLC,43,1.233E-01,6.564E-01,1.233E-01,6.564E-01,3,"STAT3, p38alpha (MAPK14), Rb protein",
204,"Chemotaxis_CCL16-, CCL20-, CXCL16- and CCL25-mediated cell migration",43,1.233E-01,6.564E-01,1.233E-01,6.564E-01,3,"CCR5, CCR8, MLCK",
205,"NF-kB-, AP-1- and MAPKs-mediated proinflammatory cytokine production by eosinophils in asthma",43,1.233E-01,6.564E-01,1.233E-01,6.564E-01,3,"CCL17, Tryptase, p38 MAPK",
206,Immune response_IL-11 signaling pathway via MEK/ERK and PI3K/AKT cascades,67,1.237E-01,6.564E-01,1.237E-01,6.564E-01,4,"Rb protein, SFK, Bone sialoprotein, YAP1 (YAp65)",
207,"Role of microRNAs in cell migration, survival and angiogenesis in colorectal cancer",67,1.237E-01,6.564E-01,1.237E-01,6.564E-01,4,"RhoB, PDCD4, Bcl-2, Clusterin",
208,Development_Dopamine-induced expression of CNTF in adult neurogenesis,22,1.289E-01,6.564E-01,1.289E-01,6.564E-01,2,"STAT3, Adenylate cyclase type V",
209,Amitraz-induced inhibition of Insulin secretion,22,1.289E-01,6.564E-01,1.289E-01,6.564E-01,2,"Adenylate cyclase type V, Alpha-2A adrenergic receptor",
210,T regulatory cell migration in asthma,22,1.289E-01,6.564E-01,1.289E-01,6.564E-01,2,"CCL17, CCR8",
211,Immune response_IL-15 signaling via JAK-STAT cascade,22,1.289E-01,6.564E-01,1.289E-01,6.564E-01,2,"STAT3, Bcl-2",
212,LRRK2 and immune function in Parkinson's disease,22,1.289E-01,6.564E-01,1.289E-01,6.564E-01,2,"MHC class II, LRRK2",
213,Development_Ligand-independent activation of ESR1 and ESR2,44,1.297E-01,6.564E-01,1.297E-01,6.564E-01,3,"Adenylate cyclase type V, ESR1 (nuclear), TFF1",
214,Influence of smoking on activation of EGFR signaling in lung cancer cells,44,1.297E-01,6.564E-01,1.297E-01,6.564E-01,3,"p38alpha (MAPK14), Amphiregulin, Adenylate cyclase",
215,Role of CD8+ Tc1 cells in COPD,44,1.297E-01,6.564E-01,1.297E-01,6.564E-01,3,"STAT3, CCR5, Bcl-2",
216,Transport_cAMP/ Ca(2+)-dependent Insulin secretion,44,1.297E-01,6.564E-01,1.297E-01,6.564E-01,3,"SUR1, Kir6.2, CACNA1D",
217,Release of pro-inflammatory factors and proteases by alveolar macrophages in asthma,44,1.297E-01,6.564E-01,1.297E-01,6.564E-01,3,"SP-A, IL-30, SP-D",
218,Apoptosis and survival_Inhibition of ROS-induced apoptosis by 17beta-estradiol,44,1.297E-01,6.564E-01,1.297E-01,6.564E-01,3,"p38alpha (MAPK14), ESR1 (mitochondrial), Bcl-2",
219,Immune response_IL-4 signaling pathway,94,1.305E-01,6.571E-01,1.305E-01,6.571E-01,5,"STAT3, p38alpha (MAPK14), Tubulin alpha, p38 MAPK, Bcl-2",
220,Mucin expression in CF airways,69,1.337E-01,6.610E-01,1.337E-01,6.610E-01,4,"p38alpha (MAPK14), Mucin 2, p38 MAPK, Mucin 5AC",
221,Possible role of neonatal nicotine exposure in development of postnatal obesity,5,1.347E-01,6.610E-01,1.347E-01,6.610E-01,1,nAChR alpha-4,
222,Cell adhesion_Ephrin signaling,45,1.362E-01,6.610E-01,1.362E-01,6.610E-01,3,"Ephrin-A receptor 8, Ephrin-A receptors, RHO6",
223,Immune response_PGE2 signaling in immune response,45,1.362E-01,6.610E-01,1.362E-01,6.610E-01,3,"CCR5, G-CSF, Adenylate cyclase",
224,Differentiation of Th2 cells in asthma,45,1.362E-01,6.610E-01,1.362E-01,6.610E-01,3,"MHC class II, CCR5, CCL17",
225,G-protein signaling_Regulation of Cyclic AMP levels by ACM,45,1.362E-01,6.610E-01,1.362E-01,6.610E-01,3,"Adenylate cyclase type IV, Adenylate cyclase type V, Adenylate cyclase type II",
226,Role of DNA methylation in progression of multiple myeloma,45,1.362E-01,6.610E-01,1.362E-01,6.610E-01,3,"STAT3, ESR1 (nuclear), Dexras1",
227,FGF signaling in gastric cancer,23,1.387E-01,6.610E-01,1.387E-01,6.610E-01,2,"FGFR4, FGFR1",
228,Action of GSK3 beta in bipolar disorder,23,1.387E-01,6.610E-01,1.387E-01,6.610E-01,2,"Tau (MAPT), Bcl-2",
229,Role of Leptin in regulation of eating behavior in obesity,23,1.387E-01,6.610E-01,1.387E-01,6.610E-01,2,"STAT3, CART",
230,Hypertrophy of  asthmatic airway smooth muscle cells ,70,1.389E-01,6.610E-01,1.389E-01,6.610E-01,4,"STAT3, Rb protein, MLCK, C/EBPalpha",
231,Th2-cytokine-induced airway epithelium mucous metaplasia in COPD,70,1.389E-01,6.610E-01,1.389E-01,6.610E-01,4,"PP2A regulatory, HAG-2, Mucin 5AC, PDEF",
232,Tumor metabolic pathways promoting development of Treg cells,96,1.390E-01,6.610E-01,1.390E-01,6.610E-01,5,"STAT3, MHC class II, CCR5, CCL17, FGFR1",
233,Immune response_Naive CD4+ T cell differentiation,46,1.428E-01,6.620E-01,1.428E-01,6.620E-01,3,"STAT3, GATA-3, MHC class II",
234,Role of GIP in pathogenesis of type 2 diabetes,46,1.428E-01,6.620E-01,1.428E-01,6.620E-01,3,"p38alpha (MAPK14), p38 MAPK, Bcl-2",
235,Apoptosis and survival_IL-17-induced CIKS-independent signaling pathways,46,1.428E-01,6.620E-01,1.428E-01,6.620E-01,3,"STAT3, p38alpha (MAPK14), p38 MAPK",
236,Neurophysiological process_Receptor-mediated axon growth repulsion,46,1.428E-01,6.620E-01,1.428E-01,6.620E-01,3,"Ephrin-A receptors, Tau (MAPT), RHO6",
237,Transcription_Hypoxia- and receptor-mediated HIF-1 activation,46,1.428E-01,6.620E-01,1.428E-01,6.620E-01,3,"STAT3, LRRK2, p38 MAPK",
238,Transcription_Androgen Receptor nuclear signaling,46,1.428E-01,6.620E-01,1.428E-01,6.620E-01,3,"STAT3, Androgen receptor, Kallikrein 3 (PSA)",
239,Development_Stimulation of differentiation of mouse embryonic fibroblasts into adipocytes by extracellular factors,71,1.441E-01,6.637E-01,1.441E-01,6.637E-01,4,"A-FABP, p38 MAPK, Adenylate cyclase, C/EBPalpha",
240,Retinoic acid regulation of oligodendrocyte differentiation in multiple sclerosis,24,1.486E-01,6.637E-01,1.486E-01,6.637E-01,2,"OLIG1, Transthyretin",
241,Development_Schema: SMAD-dependent TGF-beta family signaling in embryonic stem cells,24,1.486E-01,6.637E-01,1.486E-01,6.637E-01,2,"BMP7, SOX2",
242,Immune response_PGE2 in immune and neuroendocrine system interactions,47,1.496E-01,6.637E-01,1.496E-01,6.637E-01,3,"p38alpha (MAPK14), PGE2R3, p38 MAPK",
243,Role of proinflammatory cytokines in activation of p53 in major depressive disorder,47,1.496E-01,6.637E-01,1.496E-01,6.637E-01,3,"Rb protein, Bcl-2, Reprimo",
244,Chemotaxis_Lipoxin inhibitory action on Formyl-Met-Leu-Phe-induced neutrophil chemotaxis,47,1.496E-01,6.637E-01,1.496E-01,6.637E-01,3,"Hck, p38 MAPK, PREX1",
245,Reproduction_Gonadotropin-releasing hormone (GnRH) signaling,73,1.547E-01,6.637E-01,1.547E-01,6.637E-01,4,"p38alpha (MAPK14), MKP-2, CG alpha, Adenylate cyclase",
246,Mast cell migration in asthma,73,1.547E-01,6.637E-01,1.547E-01,6.637E-01,4,"CCL17, IL8RA, p38 MAPK, FGFR1",
247,Regulation and signaling of HGF receptor (Met) and MSP receptor (RON) in lung cancer,73,1.547E-01,6.637E-01,1.547E-01,6.637E-01,4,"STAT3, p38alpha (MAPK14), Rb protein, Delta-catenin",
248,Common mechanisms of Th17 cell migration,48,1.564E-01,6.637E-01,1.564E-01,6.637E-01,3,"Collagen II, CCR5, CCL17",
249,Immune response_C3a signaling,48,1.564E-01,6.637E-01,1.564E-01,6.637E-01,3,"MHC class II, p38 MAPK, Adenylate cyclase",
250,Main genetic and epigenetic alterations in lung cancer,48,1.564E-01,6.637E-01,1.564E-01,6.637E-01,3,"Rb protein, IBP, Bcl-2",
251,Development_Adiponectin signaling,48,1.564E-01,6.637E-01,1.564E-01,6.637E-01,3,"STAT3, p38alpha (MAPK14), Adiponectin",
252,K-RAS signaling in lung cancer,48,1.564E-01,6.637E-01,1.564E-01,6.637E-01,3,"Amphiregulin, RhoB, PDCD4",
253,IL-17-induced mucin expression in CF airways,48,1.564E-01,6.637E-01,1.564E-01,6.637E-01,3,"MHC class II, p38 MAPK, Mucin 5AC",
254,Immune response_IL-12 signaling pathway,48,1.564E-01,6.637E-01,1.564E-01,6.637E-01,3,"STAT3, p38alpha (MAPK14), GADD45 gamma",
255,Macrophage and dendritic cell phenotype shift in cancer,100,1.569E-01,6.637E-01,1.569E-01,6.637E-01,5,"STAT3, MHC class II, ESR1 (nuclear), XBP1, p38 MAPK",
256,Development_Trophectoderm differentiation,25,1.586E-01,6.637E-01,1.586E-01,6.637E-01,2,"FGF4, SOX2",
257,Immune response_IL-2 signaling via JAK/ STAT,25,1.586E-01,6.637E-01,1.586E-01,6.637E-01,2,"STAT3, Bcl-2",
258,Transcription_Transcription regulation of aminoacid metabolism,25,1.586E-01,6.637E-01,1.586E-01,6.637E-01,2,"p38alpha (MAPK14), Rb protein",
259,HBV-dependent transcription regulation leading to HCC,25,1.586E-01,6.637E-01,1.586E-01,6.637E-01,2,"ESR1 (nuclear), EGR3",
260,Cytoskeleton remodeling_Neurofilaments,25,1.586E-01,6.637E-01,1.586E-01,6.637E-01,2,"Tubulin alpha, Peripherin",
261,Fenofibrate in treatment of type 2 diabetes and metabolic syndrome X,25,1.586E-01,6.637E-01,1.586E-01,6.637E-01,2,"Adiponectin, ABCG1",
262,Resolution of inflammation in healing myocardial infarction,25,1.586E-01,6.637E-01,1.586E-01,6.637E-01,2,"STAT3, G-CSF",
263,Development_Schema: Methods of somatic cell reprogramming into induced pluripotent stem cells,6,1.593E-01,6.637E-01,1.593E-01,6.637E-01,1,SOX2,
264,Signal transduction_mTORC1 upstream signaling,74,1.601E-01,6.637E-01,1.601E-01,6.637E-01,4,"p38alpha (MAPK14), DEPTOR, p38 MAPK, GHR",
265,Signal transduction_HTR2A signaling outside the nervous system,74,1.601E-01,6.637E-01,1.601E-01,6.637E-01,4,"STAT3, Rb protein, p38 MAPK, Adenylate cyclase",
266,SLE genetic marker-specific pathways in T cells,101,1.615E-01,6.637E-01,1.615E-01,6.637E-01,5,"STAT3, MHC class II, ESR1 (nuclear), MHC class II beta chain, Bcl-2",
267,Chemotaxis_Lysophosphatidic acid signaling via GPCRs,129,1.629E-01,6.637E-01,1.629E-01,6.637E-01,6,"Rho GTPase, IL13RA2, p38 MAPK, Bcl-2, YAP1 (YAp65), PREX1",
268,Regulation of lipid metabolism_Regulation of lipid metabolism by niacin and isoprenaline,49,1.633E-01,6.637E-01,1.633E-01,6.637E-01,3,"Adenylate cyclase type IV, Adenylate cyclase type V, Adenylate cyclase type II",
269,Th17 cells in CF (mouse model),49,1.633E-01,6.637E-01,1.633E-01,6.637E-01,3,"STAT3, MHC class II, G-CSF",
270,Transport_ACM3 signaling in lacrimal glands,75,1.656E-01,6.637E-01,1.656E-01,6.637E-01,4,"MaxiK alpha subunit, SP-A, SP-D, Lacritin",
271,EGFR family signaling in pancreatic cancer,75,1.656E-01,6.637E-01,1.656E-01,6.637E-01,4,"STAT3, Rb protein, p38 MAPK, Bcl-2",
272,Glyoxylate metabolism,26,1.688E-01,6.637E-01,1.688E-01,6.637E-01,2,"AGT2, AGXT",
273,G-protein signaling_Ras family GTPases in kinase cascades,26,1.688E-01,6.637E-01,1.688E-01,6.637E-01,2,"p38alpha (MAPK14), p38 MAPK",
274,Downregulation of MITF in melanoma,26,1.688E-01,6.637E-01,1.688E-01,6.637E-01,2,"STAT3, PAX3",
275,Immune response_Role of HMGB1 in dendritic cell maturation and migration,26,1.688E-01,6.637E-01,1.688E-01,6.637E-01,2,"MHC class II, p38 MAPK",
276,Signal transduction_HTR2A-dependent arachidonic acid production,26,1.688E-01,6.637E-01,1.688E-01,6.637E-01,2,"RhoA-related, p38 MAPK",
277,"Cigarette smoke-induced proliferation, metaplasia and survival of airway epithelial cells ",50,1.703E-01,6.637E-01,1.703E-01,6.637E-01,3,"p38alpha (MAPK14), Amphiregulin, nAChR alpha-4",
278,Rheumatoid arthritis (general schema),50,1.703E-01,6.637E-01,1.703E-01,6.637E-01,3,"MHC class II, Collagen II, MHC class II beta chain",
279,Proteases and EGFR-activated mucin production in airway epithelium in COPD,50,1.703E-01,6.637E-01,1.703E-01,6.637E-01,3,"p38 MAPK, Mucin 5AC, Bcl-2",
280,Survival pathways in Prostate Cancer,50,1.703E-01,6.637E-01,1.703E-01,6.637E-01,3,"STAT3, Androgen receptor, Bcl-2",
281,Immune response_IFN-gamma in macrophages activation,50,1.703E-01,6.637E-01,1.703E-01,6.637E-01,3,"IL-30, DEPTOR, Selenoprotein P",
282,The role of PTEN and PI3K signaling in melanoma,50,1.703E-01,6.637E-01,1.703E-01,6.637E-01,3,"STAT3, Tau (MAPT), Epo",
283,Immune response_C5a signaling,50,1.703E-01,6.637E-01,1.703E-01,6.637E-01,3,"p38 MAPK, Bcl-2, PREX1",
284,"Development_Hedgehog, BMP and Parathyroid hormone in osteogenesis",51,1.774E-01,6.817E-01,1.774E-01,6.817E-01,3,"BMP7, Bone sialoprotein, Adenylate cyclase",
285,Development_Oligodendrocyte differentiation from adult stem cells,51,1.774E-01,6.817E-01,1.774E-01,6.817E-01,3,"OATP-A, p38 MAPK, FGFR1",
286,Development_Beta-adrenergic receptors signaling via Cyclic AMP,51,1.774E-01,6.817E-01,1.774E-01,6.817E-01,3,"p38 MAPK, Adenylate cyclase, Perilipin",
287,Regulation of angiogenesis in prostate cancer,51,1.774E-01,6.817E-01,1.774E-01,6.817E-01,3,"Androgen receptor, IL8RA, IL8RB",
288,Activation of osteoclast differentiation in bone lesions formation in multiple myeloma,27,1.790E-01,6.833E-01,1.790E-01,6.833E-01,2,"CCR5, p38 MAPK",
289,Neurophysiological process_Sweet taste signaling,27,1.790E-01,6.833E-01,1.790E-01,6.833E-01,2,"P2X2, Gustducin",
290,Regulatory T cells in human allergic contact dermatitis,7,1.833E-01,6.843E-01,1.833E-01,6.843E-01,1,MHC class II,
291,Gamma-aminobutyrate (GABA) biosynthesis and metabolism,52,1.845E-01,6.843E-01,1.845E-01,6.843E-01,3,"GABT, ABP1, DHE4",
292,Development_Self-renewal of adult neural stem cells,52,1.845E-01,6.843E-01,1.845E-01,6.843E-01,3,"NeuroD2, NeuroD4, SOX2",
293,Nicotine signaling in cholinergic neurons,52,1.845E-01,6.843E-01,1.845E-01,6.843E-01,3,"Tau (MAPT), CHT1, nAChR alpha-4",
294,Impaired inhibition of Th17 cell differentiation by IFN-beta in multiple sclerosis,28,1.894E-01,6.843E-01,1.894E-01,6.843E-01,2,"STAT3, IL-30",
295,Neurophysiological process_Role of CDK5 in presynaptic signaling,28,1.894E-01,6.843E-01,1.894E-01,6.843E-01,2,"TY3H, Amphiphysin I",
296,GLP-1 in inhibition of insulin secretion in type 2 diabetes,28,1.894E-01,6.843E-01,1.894E-01,6.843E-01,2,"Kir6.2, CACNA1D",
297,Possible influence of low doses of Arsenite on glucose uptake in muscle,28,1.894E-01,6.843E-01,1.894E-01,6.843E-01,2,"MYOG, MYOD",
298,Regulation of Beta-catenin activity  in melanoma,28,1.894E-01,6.843E-01,1.894E-01,6.843E-01,2,"NRCAM, Bcl-2",
299,Role of Th17 cells in asthma,28,1.894E-01,6.843E-01,1.894E-01,6.843E-01,2,"p38 MAPK, IL8RB",
300,Chemotaxis_Inhibitory action of lipoxins on IL-8- and Leukotriene B4-induced neutrophil migration,53,1.918E-01,6.843E-01,1.918E-01,6.843E-01,3,"IL8RA, MLCK, PREX1",
301,Development_Role of HDAC and calcium/calmodulin-dependent kinase (CaMK) in control of skeletal myogenesis,53,1.918E-01,6.843E-01,1.918E-01,6.843E-01,3,"p38alpha (MAPK14), MYOG, MYOD",
302,Proinflammatory cytokine production by Th17 cells in asthma,53,1.918E-01,6.843E-01,1.918E-01,6.843E-01,3,"STAT3, GATA-3, MHC class II",
303,Chemotaxis_CCR1 signaling,53,1.918E-01,6.843E-01,1.918E-01,6.843E-01,3,"STAT3, p38 MAPK, Adenylate cyclase",
304,Non-genomic signaling of ESR2 (membrane) in lung cancer cells,53,1.918E-01,6.843E-01,1.918E-01,6.843E-01,3,"Amphiregulin, Adenylate cyclase, nAChR alpha-4",
305,EGFR signaling pathway in lung cancer,53,1.918E-01,6.843E-01,1.918E-01,6.843E-01,3,"STAT3, Amphiregulin, Bcl-2",
306,Main pathways of Schwann cells transformation in neurofibromatosis type 1 ,80,1.941E-01,6.843E-01,1.941E-01,6.843E-01,4,"Amphiregulin, B-FABP, p38 MAPK, Bcl-2",
307,GTP metabolism,54,1.991E-01,6.843E-01,1.991E-01,6.843E-01,3,"GUCY1B2, Guanylate cyclase beta, Guanylate cyclase 2D (RETGC1)",
308,Immune response_IFN-gamma actions on extracellular matrix and cell differentiation,54,1.991E-01,6.843E-01,1.991E-01,6.843E-01,3,"Collagen II, MYOG, MYOD",
309,"Disruption of apoptosis, proliferation and shedding of epithelial cells in asthma",54,1.991E-01,6.843E-01,1.991E-01,6.843E-01,3,"Amphiregulin, Rb protein, Bcl-2",
310,Eosinophil granule protein release in asthma,54,1.991E-01,6.843E-01,1.991E-01,6.843E-01,3,"Tryptase, p38 MAPK, CAMP",
311,Role of ER stress in obesity and type 2 diabetes,54,1.991E-01,6.843E-01,1.991E-01,6.843E-01,3,"Adiponectin, XBP1, C/EBPalpha",
312,ERBB family and HGF signaling in gastric cancer,54,1.991E-01,6.843E-01,1.991E-01,6.843E-01,3,"STAT3, Amphiregulin, p38 MAPK",
313,Apoptosis and survival_nAChR in apoptosis inhibition and cell cycle progression,29,1.998E-01,6.843E-01,1.998E-01,6.843E-01,2,"Rb protein, nAChR alpha",
314,Adiponectin in pathogenesis of type 2 diabetes,29,1.998E-01,6.843E-01,1.998E-01,6.843E-01,2,"p38alpha (MAPK14), Adiponectin",
315,Bone metastases in Prostate Cancer,29,1.998E-01,6.843E-01,1.998E-01,6.843E-01,2,"Bone sialoprotein, Kallikrein 3 (PSA)",
316,Apoptosis and survival_p53-dependent apoptosis,29,1.998E-01,6.843E-01,1.998E-01,6.843E-01,2,"p38alpha (MAPK14), Bcl-2",
317,Immune response_CD137 signaling in immune cell,29,1.998E-01,6.843E-01,1.998E-01,6.843E-01,2,"p38 MAPK, Bcl-2",
318,Development_Auditory hair cell differentiation in embryogenesis,29,1.998E-01,6.843E-01,1.998E-01,6.843E-01,2,"SOX2, FGFR1",
319,Immune response_Platelet activating factor/ PTAFR pathway signaling,55,2.065E-01,6.843E-01,2.065E-01,6.843E-01,3,"STAT3, p38 MAPK, Adenylate cyclase",
320,Tau pathology in Alzheimer disease,55,2.065E-01,6.843E-01,2.065E-01,6.843E-01,3,"p38alpha (MAPK14), Tau (MAPT), p38 MAPK",
321,Cell adhesion_ECM remodeling,55,2.065E-01,6.843E-01,2.065E-01,6.843E-01,3,"Collagen II, IL8RA, Kallikrein 3 (PSA)",
322,Basophil migration in asthma,55,2.065E-01,6.843E-01,2.065E-01,6.843E-01,3,"FPRL2, IL8RA, IL8RB",
323,Proteases and EGFR-induced mucin synthesis in normal and asthmatic epithelium,55,2.065E-01,6.843E-01,2.065E-01,6.843E-01,3,"Amphiregulin, Mucin 2, Mucin 5AC",
324,Role of Thyroid hormone in regulation of oligodendrocyte differentiation in multiple sclerosis,55,2.065E-01,6.843E-01,2.065E-01,6.843E-01,3,"OLIG1, OATP-A, Transthyretin",
325,Development_Fetal brown fat cell differentiation,55,2.065E-01,6.843E-01,2.065E-01,6.843E-01,3,"Adenylate cyclase, C/EBPalpha, Prolactin receptor",
326,Inhibition of mast cell functions by Siglecs in asthma,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"SIGLEC5, Siglec-6",
327,Protein folding and maturation_POMC processing,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"NAT-1, PC2",
328,Role of histone modificators in progression of multiple myeloma,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"Rb protein, Tubulin alpha",
329,Inhibition of Ephrin receptors in colorectal cancer,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"Ephrin-A receptor 7, Ephrin-A receptors",
330,T regulatory cells in asthma,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"STAT3, MHC class II",
331,Development_WNT/Beta-catenin signaling in cell differentiation,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"Islet-1, MYOD",
332,Role of prenatal nicotine exposure in apoptosis and proliferation of pancreatic beta cells,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"Bcl-2, nAChR alpha-4",
333,DNA damage_Brca1 as a transcription regulator,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"Rb protein, ESR1 (nuclear)",
334,Transcription_Ligand-dependent activation of the ESR1/SP pathway,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"ESR1 (nuclear), Prolactin receptor",
335,Colorectal cancer (general schema),30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"IL8RA, IL8RB",
336,Role of adipose tissue hypoxia in obesity and type 2 diabetes,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"Adiponectin, C/EBPalpha",
337,Neurophysiological process_nNOS signaling in neuronal synapses,30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"CAPON, Dexras1",
338,Signal transduction_Additional pathways of NF-kB activation (in the nucleus),30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"p38alpha (MAPK14), Adenylate cyclase",
339,Putative pathways of Oleic acid sensing in ventromedial hypothalamus in obesity (rodent model),30,2.103E-01,6.843E-01,2.103E-01,6.843E-01,2,"SUR1, Kir6.2",
340,Apoptosis and survival_Endoplasmic reticulum stress response pathway,56,2.139E-01,6.899E-01,2.139E-01,6.899E-01,3,"p38alpha (MAPK14), XBP1, Bcl-2",
341,Development_Keratinocyte differentiation,56,2.139E-01,6.899E-01,2.139E-01,6.899E-01,3,"p38alpha (MAPK14), Keratin 1, C/EBPalpha",
342,Impaired inhibitory action of lipoxins on neutrophil migration in CF,56,2.139E-01,6.899E-01,2.139E-01,6.899E-01,3,"IL8RA, MLCK, PREX1",
343,Neurophysiological process_Kappa-type opioid receptor in transmission of nerve impulses,31,2.209E-01,6.977E-01,2.209E-01,6.977E-01,2,"EBP50, Kir3.1",
344,Putative glucocorticoid- and LABA-mediated inhibition of pro-fibrotic signaling in airway fibroblasts/myofibroblasts,31,2.209E-01,6.977E-01,2.209E-01,6.977E-01,2,"p38 MAPK, C/EBPalpha",
345,NETosis in SLE,31,2.209E-01,6.977E-01,2.209E-01,6.977E-01,2,"p38 MAPK, CAMP",
346,Autocrine production of eosinophil pro-survival cytokines in asthma,31,2.209E-01,6.977E-01,2.209E-01,6.977E-01,2,"YB-1, p38 MAPK",
347,Inhibition of TGF-beta signaling in lung cancer,31,2.209E-01,6.977E-01,2.209E-01,6.977E-01,2,"p38alpha (MAPK14), Rb protein",
348,Influence of low doses of Arsenite on glucose uptake in adipocytes,31,2.209E-01,6.977E-01,2.209E-01,6.977E-01,2,"A-FABP, C/EBPalpha",
349,Role of nicotine in pathogenesis of SCLC,57,2.214E-01,6.977E-01,2.214E-01,6.977E-01,3,"GRP-R, Bcl-2, IL8RB",
350,Apoptotic pathways and resistance to apoptosis in lung cancer cells,57,2.214E-01,6.977E-01,2.214E-01,6.977E-01,3,"PEA15, FGFR1, Bcl-2",
351,Development_Prolactin receptor signaling,58,2.290E-01,7.072E-01,2.290E-01,7.072E-01,3,"STAT3, Bcl-2, Prolactin receptor",
352,Hyaluronic acid/ CD44 signaling in cancer,58,2.290E-01,7.072E-01,2.290E-01,7.072E-01,3,"STAT3, ESR1 (nuclear), PDCD4",
353,Role of integrins in eosinophil degranulation in asthma,58,2.290E-01,7.072E-01,2.290E-01,7.072E-01,3,"Hck, p38 MAPK, SP-D",
354,TGF-beta signaling via kinase cascades in breast cancer,58,2.290E-01,7.072E-01,2.290E-01,7.072E-01,3,"p38alpha (MAPK14), Amphiregulin, p38 MAPK",
355,Immune response_CCR5 signaling in macrophages and T lymphocytes,58,2.290E-01,7.072E-01,2.290E-01,7.072E-01,3,"STAT3, CCR5, p38 MAPK",
356,Cytoskeleton remodeling_Regulation of actin cytoskeleton organization by the kinase effectors of Rho GTPases,58,2.290E-01,7.072E-01,2.290E-01,7.072E-01,3,"RhoA-related, RhoB, MLCK",
357,Role of B cells in SLE,58,2.290E-01,7.072E-01,2.290E-01,7.072E-01,3,"Fc gamma RII beta, MHC class II, Bcl-2",
358,EML4/ALK fusion protein in nonsmoking-related lung cancer ,32,2.314E-01,7.072E-01,2.314E-01,7.072E-01,2,"STAT3, TITF1",
359,Th2 cytokine-induced alternative activation of alveolar macrophages in asthma,32,2.314E-01,7.072E-01,2.314E-01,7.072E-01,2,"CCL17, TFF2",
360,Neurophysiological process_Glucose-excited neurons of ventromedial nucleus (rodent model),32,2.314E-01,7.072E-01,2.314E-01,7.072E-01,2,"SUR1, Kir6.2",
361,Cytoskeleton remodeling_Reverse signaling by Ephrin-B,32,2.314E-01,7.072E-01,2.314E-01,7.072E-01,2,"Tau (MAPT), Tubulin alpha",
362,Renal secretion of inorganic electrolytes,59,2.365E-01,7.163E-01,2.365E-01,7.163E-01,3,"SLC12A1, Carbonic anhydrase IV, Klotho",
363,Development_Regulation of cytoskeleton proteins in oligodendrocyte differentiation and myelination,59,2.365E-01,7.163E-01,2.365E-01,7.163E-01,3,"Tau (MAPT), Tubulin alpha, KLHL1",
364,Transcription_Role of VDR in regulation of genes involved in osteoporosis,59,2.365E-01,7.163E-01,2.365E-01,7.163E-01,3,"Androgen receptor, Calcitonin receptor, CG alpha",
365,Influence of multiple myeloma cells on bone marrow stromal cells,33,2.421E-01,7.163E-01,2.421E-01,7.163E-01,2,"FGFR4, FGFR1",
366,IL-2 as a growth factor for T cells in multiple sclerosis,33,2.421E-01,7.163E-01,2.421E-01,7.163E-01,2,"Rb protein, Bcl-2",
367,Apoptosis and survival_Granzyme B signaling,33,2.421E-01,7.163E-01,2.421E-01,7.163E-01,2,"Tubulin alpha, FGFR1",
368,Nicotine signaling in glutamatergic neurons,33,2.421E-01,7.163E-01,2.421E-01,7.163E-01,2,"Adenylate cyclase type V, nAChR alpha-4",
369,Development_EGF-induced proliferation of Type C cells in SVZ of adult brain,33,2.421E-01,7.163E-01,2.421E-01,7.163E-01,2,"SOX2, Prolactin receptor",
370,Chemotaxis_CCL19- and CCL21-mediated chemotaxis,33,2.421E-01,7.163E-01,2.421E-01,7.163E-01,2,"p38 MAPK, Adenylate cyclase",
371,IGF family signaling in colorectal cancer,60,2.442E-01,7.163E-01,2.442E-01,7.163E-01,3,"IBP, C/EBPalpha, Clusterin",
372,Signal transduction_MIF signaling pathway,60,2.442E-01,7.163E-01,2.442E-01,7.163E-01,3,"SFK, Bcl-2, IL8RB",
373,Signal transduction_mTORC1 downstream signaling,60,2.442E-01,7.163E-01,2.442E-01,7.163E-01,3,"STAT3, HMGCS2, PDCD4",
374,Development_Thyroliberin signaling,60,2.442E-01,7.163E-01,2.442E-01,7.163E-01,3,"Thyroliberin, CG alpha, Adenylate cyclase",
375,Immune response_IL-17 signaling pathways,60,2.442E-01,7.163E-01,2.442E-01,7.163E-01,3,"G-CSF, p38 MAPK, Mucin 5AC",
376,Oxidative stress_ROS-mediated MAPK activation via canonical pathways,60,2.442E-01,7.163E-01,2.442E-01,7.163E-01,3,"SFK, p38 MAPK, FGFR1",
377,Neolacto-series GSL Metabolism p.2,61,2.519E-01,7.240E-01,2.519E-01,7.240E-01,3,"FUT6, GALGT2, CHST1",
378,Signal transduction_Erk Interactions: Inhibition of Erk,34,2.527E-01,7.240E-01,2.527E-01,7.240E-01,2,"MKP-2, PEA15",
379,Th2 cell migration in asthma,34,2.527E-01,7.240E-01,2.527E-01,7.240E-01,2,"CCL17, CCR8",
380,NK cells in allergic contact dermatitis,34,2.527E-01,7.240E-01,2.527E-01,7.240E-01,2,"MHC class II, CCR5",
381,Development_Role of CDK5 in neuronal development,34,2.527E-01,7.240E-01,2.527E-01,7.240E-01,2,"Delta-catenin, Tau (MAPT)",
382,G-protein signaling_RhoA regulation pathway,34,2.527E-01,7.240E-01,2.527E-01,7.240E-01,2,"Ephrin-A receptors, Rhophilin 1",
383,Development_BMP signaling in cardiac myogenesis,34,2.527E-01,7.240E-01,2.527E-01,7.240E-01,2,"BMP7, p38 MAPK",
384,G-protein signaling_G-Protein beta/gamma signaling cascades,34,2.527E-01,7.240E-01,2.527E-01,7.240E-01,2,"Adenylate cyclase type V, Adenylate cyclase type II",
385,Oxidative stress_ROS-mediated activation of MAPK via inhibition of phosphatases,34,2.527E-01,7.240E-01,2.527E-01,7.240E-01,2,"PP2A regulatory, p38 MAPK",
386,Heparan sulfate/heparin metabolism,62,2.596E-01,7.299E-01,2.596E-01,7.299E-01,3,"HSST4, 3-OST5, HS6ST3",
387,Regulation of intrinsic membrane properties and excitability of striatonigral medium spiny neurons in Huntington's disease,62,2.596E-01,7.299E-01,2.596E-01,7.299E-01,3,"MaxiK alpha subunit, Adenylate cyclase type V, CACNA1D",
388,IL-6 signaling pathway in lung cancer,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"STAT3, p38 MAPK",
389,Development_Transcriptional regulation of megakaryopoiesis,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"TAL1, Glycoprotein VI",
390,Immune response_Differentiation of natural regulatory T cells,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"STAT3, MHC class II",
391,Immune response_Th17 cell differentiation,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"STAT3, MHC class II",
392,TNF-alpha and IL-1 beta induce hyperglycemia in obesity and type 2 diabetes in adipocytes,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"GM3 synthase, p38 MAPK",
393,Role of Tissue factor in cancer independent of coagulation protease signaling,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"Coagulation factor VII, p38 MAPK",
394,Beta-alanine metabolism,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"GABT, ABP1",
395,Development_Growth hormone signaling via STATs and PLC/IP3,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"STAT3, GHR",
396,Anti-apoptotic action of Gastrin in pancreatic cancer,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"p38alpha (MAPK14), Bcl-2",
397,Cell cycle_ESR1 regulation of G1/S transition,35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"Rb protein, ESR1 (nuclear)",
398,Glucose-excited neurons of arcuate nucleus in obesity (rodent model),35,2.634E-01,7.299E-01,2.634E-01,7.299E-01,2,"SUR1, Kir6.2",
399,HCV-mediated liver damage and predisposition to HCC via cell stress,63,2.673E-01,7.364E-01,2.673E-01,7.364E-01,3,"STAT3, p38alpha (MAPK14), XBP1",
400,O-glycan biosynthesis,63,2.673E-01,7.364E-01,2.673E-01,7.364E-01,3,"GALNTL3, GALNT6, B3Gn-T6",
401,G-protein signaling_Rap1B regulation pathway,11,2.726E-01,7.364E-01,2.726E-01,7.364E-01,1,Ca-ATPase3,
402,Prolactin/ ERK signaling in breast cancer,36,2.740E-01,7.364E-01,2.740E-01,7.364E-01,2,"GSTM1, Prolactin receptor",
403,Immune response_IL-6-induced acute-phase response in hepatocytes,36,2.740E-01,7.364E-01,2.740E-01,7.364E-01,2,"STAT3, Hemopexin",
404,Urea cycle,36,2.740E-01,7.364E-01,2.740E-01,7.364E-01,2,"CPSM, Aquaporin 10",
405,Cigarette smoke-induced inflammatory signaling in airway epithelial cells,36,2.740E-01,7.364E-01,2.740E-01,7.364E-01,2,"p38alpha (MAPK14), Amphiregulin",
406,Inhibition of apoptosis in multiple myeloma,36,2.740E-01,7.364E-01,2.740E-01,7.364E-01,2,"STAT3, Bcl-2",
407,Upregulation of MITF in melanoma,36,2.740E-01,7.364E-01,2.740E-01,7.364E-01,2,"Rb protein, Bcl-2",
408,Development_SSTR2 in regulation of cell proliferation,36,2.740E-01,7.364E-01,2.740E-01,7.364E-01,2,"Rb protein, SSTR2",
409,Development_Thrombospondin 1 signaling,36,2.740E-01,7.364E-01,2.740E-01,7.364E-01,2,"p38 MAPK, Adenylate cyclase",
410,Eosinophil chemotaxis in asthma,64,2.751E-01,7.364E-01,2.751E-01,7.364E-01,3,"IL8RA, CCR8, IL8RB",
411,Myeloid-derived suppressor cells and M2 macrophages in cancer,64,2.751E-01,7.364E-01,2.751E-01,7.364E-01,3,"STAT3, G-CSF, CAT-2",
412,Oxidative stress in adipocyte dysfunction in type 2 diabetes and metabolic syndrome X,64,2.751E-01,7.364E-01,2.751E-01,7.364E-01,3,"A-FABP, Adiponectin, PLA2",
413,Development_Role of IL-8 in angiogenesis,65,2.829E-01,7.458E-01,2.829E-01,7.458E-01,3,"STAT3, IL8RA, IL8RB",
414,TNF-alpha and IL-1 beta-mediated regulation of contraction and secretion of inflammatory factors in normal and asthmatic airway smooth muscle,65,2.829E-01,7.458E-01,2.829E-01,7.458E-01,3,"p38alpha (MAPK14), PLA2, p38 MAPK",
415,Neurophysiological process_Constitutive and regulated NMDA receptor trafficking,65,2.829E-01,7.458E-01,2.829E-01,7.458E-01,3,"Chapsyn-110, Adenylate cyclase, MALS",
416,Immune response_Generation of memory CD4+ T cells,37,2.847E-01,7.458E-01,2.847E-01,7.458E-01,2,"MHC class II, Bcl-2",
417,Deregulation of PSD-95-dependent signaling in Huntington's disease,37,2.847E-01,7.458E-01,2.847E-01,7.458E-01,2,"p38alpha (MAPK14), p38 MAPK",
418,Development_Retinoic acid and retinoic acid receptors in regulation of oligodendrocyte differentiation,37,2.847E-01,7.458E-01,2.847E-01,7.458E-01,2,"OLIG1, Transthyretin",
419,G-protein signaling_H-RAS regulation pathway,37,2.847E-01,7.458E-01,2.847E-01,7.458E-01,2,"RET, GFRalpha1",
420,Attenuation of IFN type I signaling in melanoma cells,37,2.847E-01,7.458E-01,2.847E-01,7.458E-01,2,"STAT3, p38alpha (MAPK14)",
421,Role of alveolar cell senescence in COPD,37,2.847E-01,7.458E-01,2.847E-01,7.458E-01,2,"p38 MAPK, Klotho",
422,Transcription_HIF-1 targets,95,2.865E-01,7.470E-01,2.865E-01,7.470E-01,4,"Carbonic anhydrase XII, SOX2, Epo, Stanniocalcin 2",
423,Histidine-glutamate-glutamine metabolism,95,2.865E-01,7.470E-01,2.865E-01,7.470E-01,4,"GABT, HUTU, DHE4, HUTH",
424,Development_Schema: Embryonal myogenesis,12,2.933E-01,7.488E-01,2.933E-01,7.488E-01,1,FGFR1,
425,Role of type 2 innate lymphoid cells in airway allergic inflammation and tissue repair,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"GATA-3, Amphiregulin",
426,Apoptosis and survival_Anti-apoptotic action of membrane-bound ESR1,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"ESR1 (membrane), Bcl-2",
427,Development_Gastrin in differentiation of the gastric mucosa,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"TFF1, TFF2",
428,Transcription_Role of AP-1 in regulation of cellular metabolism,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"HBE, CG alpha",
429,Cell adhesion_Cell-matrix glycoconjugates,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"CEACAM5, A1M",
430,Aldosterone biosynthesis and metabolism,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"AKR1C4, UGT2B4",
431,WNT signaling in invasive-type melanoma cells,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"STAT3, PAX3",
432,TNF-alpha-induced inflammatory signaling in normal and asthmatic airway epithelium,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"CCL17, p38 MAPK",
433,Role of Endothelin-1 in inflammation and vasoconstriction in Sickle cell disease,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"p38alpha (MAPK14), CCR5",
434,WNT signaling in proliferative-type melanoma cells,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"MSG1, NRCAM",
435,Cell adhesion_Tight junctions,38,2.953E-01,7.488E-01,2.953E-01,7.488E-01,2,"TITF1, WNK4",
436,Development_Thrombopoietin signaling via ERK1/2 and PI3K,67,2.985E-01,7.548E-01,2.985E-01,7.548E-01,3,"TAL1, p38 MAPK, Glycoprotein VI",
437,Development_PACAP signaling in neural cells,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"TY3H, Bcl-2",
438,Development_BMP7 in brown adipocyte differentiation,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"p38alpha (MAPK14), BMP7",
439,Role of tumor microenvironment in plexiform neurofibroma formation in neurofibromatosis type 1,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"Tryptase, p38 MAPK",
440,Transcription_p53 signaling pathway,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"Rb protein, Bcl-2",
441,HIV-1 signaling via CCR5 in macrophages and T lymphocytes,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"CCR5, p38 MAPK",
442,Resistance of melanoma cells to Apo-2L(TNFSF10)-induced apoptosis,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"STAT3, Bcl-2",
443,Development_ERBB-family signaling,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"Amphiregulin, Neuregulin 3",
444,Activation of Notch signaling in breast cancer,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"STAT3, p38 MAPK",
445,Immune response_Differentiation and clonal expansion of CD8+ T cells,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"STAT3, MHC class II",
446,Blood coagulation_Blood coagulation,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"Alpha 1-antitrypsin, Coagulation factor VII",
447,Cooperative action of IFN-gamma and TNF-alpha on astrocytes in multiple sclerosis,39,3.059E-01,7.548E-01,3.059E-01,7.548E-01,2,"MHC class II, Adenylate cyclase",
448,SLE genetic marker-specific pathways in B cells,99,3.122E-01,7.655E-01,3.122E-01,7.655E-01,4,"Fc gamma RII beta, BANK, XBP1, Bcl-2",
449,Calcium-dependent regulation of normal and asthmatic smooth muscle contraction,69,3.142E-01,7.655E-01,3.142E-01,7.655E-01,3,"Tryptase, Neurokinin B, MLCK",
450,Stem cells_NOTCH1-induced self-renewal of glioblastoma stem cells,40,3.165E-01,7.655E-01,3.165E-01,7.655E-01,2,"STAT3, SOX2",
451,Development_H3K27 demethylases in differentiation of stem cells,40,3.165E-01,7.655E-01,3.165E-01,7.655E-01,2,"HOXB2, HOXB1",
452,Immune response_Th1 and Th2 cell differentiation,40,3.165E-01,7.655E-01,3.165E-01,7.655E-01,2,"GATA-3, MHC class II",
453,The role of UV radiation in melanoma development,40,3.165E-01,7.655E-01,3.165E-01,7.655E-01,2,"Amphiregulin, p38 MAPK",
454,Recurrent gene fusions in Prostate Cancer,40,3.165E-01,7.655E-01,3.165E-01,7.655E-01,2,"Androgen receptor, ERG",
455,Neurophysiological process_ACM1 and ACM2 in neuronal membrane polarization,40,3.165E-01,7.655E-01,3.165E-01,7.655E-01,2,"Kir3.1, Kir2.2",
456,Development_Astrocyte differentiation from adult stem cells,40,3.165E-01,7.655E-01,3.165E-01,7.655E-01,2,"STAT3, OLIG1",
457,Development_Growth hormone-releasing hormone (GH-RH) signaling,41,3.270E-01,7.825E-01,3.270E-01,7.825E-01,2,"NAV1.9, Adenylate cyclase",
458,Translation_(L)-selenoaminoacids incorporation in proteins during translation,41,3.270E-01,7.825E-01,3.270E-01,7.825E-01,2,"DIO1, Selenoprotein P",
459,Fibroblast/ myofibroblast proliferation in asthmatic airways,41,3.270E-01,7.825E-01,3.270E-01,7.825E-01,2,"Tryptase, FGFR1",
460,Regulation of beta-adrenergic receptors signaling in pancreatic cancer,41,3.270E-01,7.825E-01,3.270E-01,7.825E-01,2,"Adenylate cyclase, nAChR alpha-4",
461,Cytoskeleton remodeling_Role of PKA in cytoskeleton reorganisation,41,3.270E-01,7.825E-01,3.270E-01,7.825E-01,2,"Adenylate cyclase, MLCK",
462,Development_Positive regulation of STK3/4 (Hippo) pathway and negative regulation of YAP/TAZ function,71,3.299E-01,7.838E-01,3.299E-01,7.838E-01,3,"EBP50, Adenylate cyclase, YAP1 (YAp65)",
463,Glutathione metabolism,71,3.299E-01,7.838E-01,3.299E-01,7.838E-01,3,"GSTM1, GSTM5, GSTA3",
464,Riboflavin metabolism,14,3.331E-01,7.838E-01,3.331E-01,7.838E-01,1,ENPP1,
465,Asthma-specific pathways of airway smooth muscle cell proliferation,14,3.331E-01,7.838E-01,3.331E-01,7.838E-01,1,C/EBPalpha,
466,Type 2 diabetes (general schema),14,3.331E-01,7.838E-01,3.331E-01,7.838E-01,1,Adiponectin,
467,IL-6 signaling in tumor-associated monocytes/macrophages in breast cancer,14,3.331E-01,7.838E-01,3.331E-01,7.838E-01,1,STAT3,
468,Serotonin modulation of dopamine release in nicotine addiction,42,3.375E-01,7.838E-01,3.375E-01,7.838E-01,2,"Adenylate cyclase, nAChR alpha-4",
469,Disruption of methionine metabolism in induction and progression of HCC,42,3.375E-01,7.838E-01,3.375E-01,7.838E-01,2,"GNMT, ADH7",
470,Immune response_PIP3 signaling in B lymphocytes,42,3.375E-01,7.838E-01,3.375E-01,7.838E-01,2,"Fc gamma RII beta, PREX1",
471,Development_Growth hormone signaling via PI3K/AKT and MAPK cascades,42,3.375E-01,7.838E-01,3.375E-01,7.838E-01,2,"p38alpha (MAPK14), GHR",
472,Development_NOTCH in inhibition of WNT/Beta-catenin-induced osteogenesis,42,3.375E-01,7.838E-01,3.375E-01,7.838E-01,2,"A-FABP, C/EBPalpha",
473,Chemoresistance pathways mediated by constitutive activation of PI3K pathway and BCL-2 in small cell lung cancer,42,3.375E-01,7.838E-01,3.375E-01,7.838E-01,2,"FGFR1, Bcl-2",
474,Chylomicron dyslipidemia in type 2 diabetes and metabolic syndrome X,42,3.375E-01,7.838E-01,3.375E-01,7.838E-01,2,"APOB48 receptor, ABCG8",
475,Growth factors in regulation of oligodendrocyte precursor cells survival in multiple sclerosis,42,3.375E-01,7.838E-01,3.375E-01,7.838E-01,2,"IBP, Bcl-2",
476,"Immune response_IL-2 signaling via ERK, PI3K, and PLC-gamma",73,3.456E-01,7.976E-01,3.456E-01,7.976E-01,3,"STAT3, Rb protein, Bcl-2",
477,Regulation of metabolism_Role of Adiponectin in regulation of metabolism,43,3.480E-01,7.976E-01,3.480E-01,7.976E-01,2,"p38alpha (MAPK14), Adiponectin",
478,Neurophysiological process_HTR1A receptor signaling in neuronal cells,43,3.480E-01,7.976E-01,3.480E-01,7.976E-01,2,"Kir3.1, Adenylate cyclase",
479,ESR1 (membrane) 36 kDa isoform signaling in breast cancer,43,3.480E-01,7.976E-01,3.480E-01,7.976E-01,2,"ESR1 (membrane), Gamma-synuclein",
480,Environmental factors-induced inflammatory signaling in normal and asthmatic airway epithelium,43,3.480E-01,7.976E-01,3.480E-01,7.976E-01,2,"p38alpha (MAPK14), p38 MAPK",
481,Role of platelets in allograft rejection,43,3.480E-01,7.976E-01,3.480E-01,7.976E-01,2,"Glycoprotein VI, Kainate receptor",
482,Neurogenesis_NGF/ TrkA MAPK-mediated signaling,105,3.512E-01,7.976E-01,3.512E-01,7.976E-01,4,"TY3H, PP2A regulatory, RIN, p38 MAPK",
483,Development_Ligand-dependent activation of the ESR1/AP-1 pathway,15,3.521E-01,7.976E-01,3.521E-01,7.976E-01,1,ESR1 (nuclear),
484,Metabolic syndrome X (general schema),15,3.521E-01,7.976E-01,3.521E-01,7.976E-01,1,Adiponectin,
485,HSP22 and BAG-3-dependend macroautophagy in Huntington's disease,15,3.521E-01,7.976E-01,3.521E-01,7.976E-01,1,HSP22,
486,Role of GITR in skin sensitization,15,3.521E-01,7.976E-01,3.521E-01,7.976E-01,1,p38 MAPK,
487,Immune response_Regulatory role of C1q in platelet activation,15,3.521E-01,7.976E-01,3.521E-01,7.976E-01,1,Glycoprotein VI,
488,IGF signaling in lung cancer,44,3.584E-01,8.018E-01,3.584E-01,8.018E-01,2,"p38 MAPK, IBP",
489,K-RAS signaling in pancreatic cancer,44,3.584E-01,8.018E-01,3.584E-01,8.018E-01,2,"FGFR4, Bcl-2",
490,Development_Flt3 signaling,44,3.584E-01,8.018E-01,3.584E-01,8.018E-01,2,"FLT3, p38 MAPK",
491,Regulation of metabolism_Triiodothyronine and Thyroxine signaling,44,3.584E-01,8.018E-01,3.584E-01,8.018E-01,2,"DIO1, S14 protein",
492,Chemotaxis_C5a-induced chemotaxis,44,3.584E-01,8.018E-01,3.584E-01,8.018E-01,2,"p38alpha (MAPK14), PREX1",
493,Inhibition of remyelination in multiple sclerosis: regulation of cytoskeleton proteins,44,3.584E-01,8.018E-01,3.584E-01,8.018E-01,2,"Tau (MAPT), Tubulin alpha",
494,Renal secretion of organic electrolytes / Rodent version ,75,3.612E-01,8.066E-01,3.612E-01,8.066E-01,3,"PEPT1, NaDC-1, SLC22A8",
495,ATP metabolism,107,3.642E-01,8.115E-01,3.642E-01,8.115E-01,4,"Adenylate cyclase type IV, Adenylate cyclase type V, Adenylate cyclase type II, ENPP1",
496,Nicotine signaling in chromaffin cells,45,3.687E-01,8.133E-01,3.687E-01,8.133E-01,2,"Chapsyn-110, TY3H",
497,Neurophysiological process_Glutamic acid regulation of Dopamine D1A receptor signaling,45,3.687E-01,8.133E-01,3.687E-01,8.133E-01,2,"PP2A regulatory, Adenylate cyclase type V",
498,Immune response_TNF-R2 signaling pathways,45,3.687E-01,8.133E-01,3.687E-01,8.133E-01,2,"p38 MAPK, Bcl-2",
499,Proinflammatory mediators production and activation of basophils in asthma,45,3.687E-01,8.133E-01,3.687E-01,8.133E-01,2,"MHC class II, p38 MAPK",
500,Development_Membrane-bound ESR1: interaction with growth factors signaling,45,3.687E-01,8.133E-01,3.687E-01,8.133E-01,2,"ESR1 (membrane), ESR1 (nuclear)",
501,G-protein signaling_RhoB regulation pathway,16,3.706E-01,8.144E-01,3.706E-01,8.144E-01,1,RhoB,
502,"Mechanism of Pioglitazone/ Metformin and Rosiglitazone/ Metformin  cooperative action in Diabetes mellitus, Type 2",16,3.706E-01,8.144E-01,3.706E-01,8.144E-01,1,Adiponectin,
503,Apoptosis and survival_NGF/ TrkA PI3K-mediated signaling,77,3.769E-01,8.196E-01,3.769E-01,8.196E-01,3,"Tau (MAPT), Bcl-2, PREX1",
504,Immune response _CCR3 signaling in eosinophils,77,3.769E-01,8.196E-01,3.769E-01,8.196E-01,3,"Hck, p38 MAPK, MLCK",
505,Signal transduction_CXCR4 signaling via PI3K cascade,46,3.790E-01,8.196E-01,3.790E-01,8.196E-01,2,"DEPTOR, PREX1",
506,L-Alanine and L-cysteine metabolism,46,3.790E-01,8.196E-01,3.790E-01,8.196E-01,2,"AGT2, AGXT",
507,Cytoskeleton remodeling_Regulation of actin cytoskeleton nucleation and polymerization by Rho GTPases,46,3.790E-01,8.196E-01,3.790E-01,8.196E-01,2,"RhoA-related, RhoB",
508,Regulation of GSK3 beta in bipolar disorder,46,3.790E-01,8.196E-01,3.790E-01,8.196E-01,2,"PP2A regulatory, FGFR1",
509,EGFR signaling in Prostate Cancer,46,3.790E-01,8.196E-01,3.790E-01,8.196E-01,2,"STAT3, Androgen receptor",
510,FGF signaling in pancreatic cancer,46,3.790E-01,8.196E-01,3.790E-01,8.196E-01,2,"FGF10, FGFR1",
511,Putative mechanism of drug action for CCR5 antagonists,17,3.886E-01,8.223E-01,3.886E-01,8.223E-01,1,CCR5,
512,DeltaF508-CFTR traffic / ER-to-Golgi in CF,17,3.886E-01,8.223E-01,3.886E-01,8.223E-01,1,EBP50,
513,LRRK2 in neuronal apoptosis in Parkinson's disease,17,3.886E-01,8.223E-01,3.886E-01,8.223E-01,1,LRRK2,
514,Transition of Smoldering multiple myeloma to active multiple myeloma (schema),17,3.886E-01,8.223E-01,3.886E-01,8.223E-01,1,Rb protein,
515,G-protein signaling_Rac3 regulation pathway,17,3.886E-01,8.223E-01,3.886E-01,8.223E-01,1,Androgen receptor,
516,wtCFTR traffic / ER-to-Golgi (normal),17,3.886E-01,8.223E-01,3.886E-01,8.223E-01,1,EBP50,
517,Th9 cells in asthma,47,3.892E-01,8.223E-01,3.892E-01,8.223E-01,2,"GATA-3, MHC class II",
518,Mitogenic action of ESR1 (membrane) in breast cancer,47,3.892E-01,8.223E-01,3.892E-01,8.223E-01,2,"ESR1 (membrane), ESR1 (nuclear)",
519,Canonical Leptin pathways in breast cancer,47,3.892E-01,8.223E-01,3.892E-01,8.223E-01,2,"STAT3, ESR1 (nuclear)",
520,Immune response_PGE2 common pathways,47,3.892E-01,8.223E-01,3.892E-01,8.223E-01,2,"PGE2R3, Adenylate cyclase",
521,Transport_Alpha-2 adrenergic receptor regulation of ion channels,47,3.892E-01,8.223E-01,3.892E-01,8.223E-01,2,"Adenylate cyclase type V, Alpha-2A adrenergic receptor",
522,Development_TGF-beta-dependent induction of EMT via MAPK ,47,3.892E-01,8.223E-01,3.892E-01,8.223E-01,2,"p38alpha (MAPK14), p38 MAPK",
523,Neuropeptide signaling in pancreatic cancer,48,3.993E-01,8.341E-01,3.993E-01,8.341E-01,2,"CCK8, GRP-R",
524,"Chemokines in inflammation in adipose tissue and liver in obesity, type 2 diabetes and metabolic syndrome X",48,3.993E-01,8.341E-01,3.993E-01,8.341E-01,2,"MHC class II, CCR5",
525,Neurophysiological process_ACM regulation of nerve impulse,48,3.993E-01,8.341E-01,3.993E-01,8.341E-01,2,"CACNA1H, CACNA1I",
526,Stimulation of TGF-beta signaling in lung cancer,48,3.993E-01,8.341E-01,3.993E-01,8.341E-01,2,"TITF1, p38alpha (MAPK14)",
527,Development_Role of Thyroid hormone in regulation of oligodendrocyte differentiation,48,3.993E-01,8.341E-01,3.993E-01,8.341E-01,2,"OLIG1, OATP-A",
528,Cell adhesion_Integrin-mediated cell adhesion and migration,48,3.993E-01,8.341E-01,3.993E-01,8.341E-01,2,"Collagen II, MLCK",
529,Rb proteins signaling in multiple myeloma,18,4.061E-01,8.376E-01,4.061E-01,8.376E-01,1,Rb protein,
530,Beta-adrenergic-dependent CFTR expression,18,4.061E-01,8.376E-01,4.061E-01,8.376E-01,1,Adenylate cyclase,
531,Androgen signaling in HCC,18,4.061E-01,8.376E-01,4.061E-01,8.376E-01,1,Androgen receptor,
532,Populations of skin dendritic cells involved in contact hypersensitivity,18,4.061E-01,8.376E-01,4.061E-01,8.376E-01,1,MHC class II,
533,Stem cells_CD30 signaling in transformed embryonic stem cells,18,4.061E-01,8.376E-01,4.061E-01,8.376E-01,1,SOX2,
534,Glucocorticoids-mediated inhibition of pro-constrictory and pro-inflammatory signaling in airway smooth muscle cells,49,4.093E-01,8.376E-01,4.093E-01,8.376E-01,2,"PLA2, p38 MAPK",
535,Transcription_N-CoR/ SMRT complex-mediated epigenetic gene silencing,49,4.093E-01,8.376E-01,4.093E-01,8.376E-01,2,"ETO, HOXB1",
536,Bacterial infections in CF airways,49,4.093E-01,8.376E-01,4.093E-01,8.376E-01,2,"SP-A, SP-D",
537,IgE- and MGF-induced Fyn-mediated activation of lung mast cells in asthma,49,4.093E-01,8.376E-01,4.093E-01,8.376E-01,2,"Hck, p38 MAPK",
538,Neurophysiological process_HTR2A signaling in the nervous system,49,4.093E-01,8.376E-01,4.093E-01,8.376E-01,2,"GABA-A receptor gamma-2 subunit, SFK",
539,Signal transduction_Soluble CXCL16 signaling,49,4.093E-01,8.376E-01,4.093E-01,8.376E-01,2,"STAT3, p38 MAPK",
540,Epigenetic alterations in ovarian cancer,82,4.155E-01,8.387E-01,4.155E-01,8.387E-01,3,"Gamma-synuclein, ESR1 (nuclear), FGFR1",
541,Development_Negative regulation of WNT/Beta-catenin signaling in the cytoplasm,82,4.155E-01,8.387E-01,4.155E-01,8.387E-01,3,"CXXC4, YAP1/TAZ, YAP1 (YAp65)",
542,Development_Thromboxane A2 signaling pathway,50,4.193E-01,8.387E-01,4.193E-01,8.387E-01,2,"p38 MAPK, Adenylate cyclase",
543,Neurophysiological process_Corticoliberin signaling via CRHR1 ,50,4.193E-01,8.387E-01,4.193E-01,8.387E-01,2,"Keratin 1, Adenylate cyclase",
544,Transport_The role of AVP in regulation of Aquaporin 2 and renal water reabsorption,50,4.193E-01,8.387E-01,4.193E-01,8.387E-01,2,"p38alpha (MAPK14), MLCK",
545,Modulation of tumor response to cytotoxic T cells by hypoxia in tumors,50,4.193E-01,8.387E-01,4.193E-01,8.387E-01,2,"STAT3, Bcl-2",
546,Immune response_Inhibitory action of lipoxins on superoxide production induced by IL-8 and Leukotriene B4 in neutrophils,50,4.193E-01,8.387E-01,4.193E-01,8.387E-01,2,"IL8RA, PREX1",
547,Angiogenesis in HCC,50,4.193E-01,8.387E-01,4.193E-01,8.387E-01,2,"STAT3, Epo",
548,PDE4 regulation of cyto/chemokine expression in inflammatory skin diseases,50,4.193E-01,8.387E-01,4.193E-01,8.387E-01,2,"p38 MAPK, Adenylate cyclase",
549,Development_Alpha-1 adrenergic receptors signaling via Cyclic AMP,19,4.230E-01,8.387E-01,4.230E-01,8.387E-01,1,Adenylate cyclase,
550,Protein folding_Membrane trafficking and signal transduction of G-alpha (i) heterotrimeric G-protein,19,4.230E-01,8.387E-01,4.230E-01,8.387E-01,1,Adenylate cyclase type II,
551,HCV-mediated liver damage and predisposition to HCC progression via p53,19,4.230E-01,8.387E-01,4.230E-01,8.387E-01,1,Rb protein,
552,Cytoskeleton remodeling_Alpha-1A adrenergic receptor-dependent inhibition of PI3K,19,4.230E-01,8.387E-01,4.230E-01,8.387E-01,1,MLCK,
553,UMP biosynthesis,19,4.230E-01,8.387E-01,4.230E-01,8.387E-01,1,CPSM,
554,Immune response_ETV3 affect on CSF1-promoted macrophage differentiation,19,4.230E-01,8.387E-01,4.230E-01,8.387E-01,1,p38 MAPK,
555,Muscle contraction_GPCRs in the regulation of smooth muscle tone,83,4.231E-01,8.387E-01,4.231E-01,8.387E-01,3,"MaxiK alpha subunit, Adenylate cyclase, MLCK",
556,Tyrosine metabolism p.2 (melanin),83,4.231E-01,8.387E-01,4.231E-01,8.387E-01,3,"TAT, PERT, ABP1",
557,Immune response_Histamine signaling in dendritic cells,51,4.292E-01,8.387E-01,4.292E-01,8.387E-01,2,"Histamine H3 receptor, Adenylate cyclase",
558,IL-6 signaling in multiple myeloma,51,4.292E-01,8.387E-01,4.292E-01,8.387E-01,2,"STAT3, Rb protein",
559,Anti-apoptotic action of ErbB2 in breast cancer,51,4.292E-01,8.387E-01,4.292E-01,8.387E-01,2,"STAT3, Bcl-2",
560,Epithelial cell anoikis in COPD,51,4.292E-01,8.387E-01,4.292E-01,8.387E-01,2,"p38 MAPK, Bcl-2",
561,microRNA in Prostate Cancer,51,4.292E-01,8.387E-01,4.292E-01,8.387E-01,2,"PDCD4, Bcl-2",
562,Putative pathways of n-3 and n-6 fatty acids in obesity and type 2 diabetes,51,4.292E-01,8.387E-01,4.292E-01,8.387E-01,2,"Adiponectin, Adenylate cyclase",
563,Some pathways of EMT in cancer cells,51,4.292E-01,8.387E-01,4.292E-01,8.387E-01,2,"STAT3, Bcl-2",
564,Th2 cytokine- and TNF-alpha-induced profibrotic response in asthmatic airway fibroblasts/ myofibroblasts,52,4.389E-01,8.387E-01,4.389E-01,8.387E-01,2,"IL13RA2, p38 MAPK",
565,Development_Endothelin-1/EDNRA signaling,52,4.389E-01,8.387E-01,4.389E-01,8.387E-01,2,"p38alpha (MAPK14), Adenylate cyclase",
566,Immune response_Lysophosphatidic acid signaling via NF-kB,52,4.389E-01,8.387E-01,4.389E-01,8.387E-01,2,"PEA15, p38 MAPK",
567,IGF signaling in HCC,52,4.389E-01,8.387E-01,4.389E-01,8.387E-01,2,"IRS-4, Amphiregulin",
568,Stem cells_mGluR3 signaling in glioblastoma stem cells,52,4.389E-01,8.387E-01,4.389E-01,8.387E-01,2,"SLC1A2/EAAT2, Adenylate cyclase",
569,Immune response_T cell subsets: cell surface markers,52,4.389E-01,8.387E-01,4.389E-01,8.387E-01,2,"CCR5, CCR8",
570,Development_Direct reprogramming of cardiac fibroblasts into cardiomyocytes,20,4.395E-01,8.387E-01,4.395E-01,8.387E-01,1,Islet-1,
571,Development_FGF2-dependent induction of EMT,20,4.395E-01,8.387E-01,4.395E-01,8.387E-01,1,FGFR1,
572,HBV mediates angiogenesis in HCC,20,4.395E-01,8.387E-01,4.395E-01,8.387E-01,1,STAT3,
573,Development_H3K36 demethylation in stem cell maintenance,20,4.395E-01,8.387E-01,4.395E-01,8.387E-01,1,Rb protein,
574,Mechanisms of hapten presentation to T cells in allergic contact dermatitis,20,4.395E-01,8.387E-01,4.395E-01,8.387E-01,1,MHC class II,
575,DNA damage_Inhibition of telomerase activity and cellular senescence,20,4.395E-01,8.387E-01,4.395E-01,8.387E-01,1,Rb protein,
576,Role of XBP1 protein in multiple myeloma,20,4.395E-01,8.387E-01,4.395E-01,8.387E-01,1,XBP1,
577,wtCFTR and deltaF508-CFTR traffic / Clathrin coated vesicles formation (normal and CF),20,4.395E-01,8.387E-01,4.395E-01,8.387E-01,1,Myosin I,
578,Protein folding and maturation_Insulin processing,20,4.395E-01,8.387E-01,4.395E-01,8.387E-01,1,PC2,
579,Aryl hydrocarbon receptor signaling,53,4.486E-01,8.424E-01,4.486E-01,8.424E-01,2,"TY3H, ESR1 (nuclear)",
580,Immune response_HMGB1/RAGE signaling pathway,53,4.486E-01,8.424E-01,4.486E-01,8.424E-01,2,"p38 MAPK, MYOG",
581,Effect of H. pylori infection on apoptosis in gastric epithelial cells,53,4.486E-01,8.424E-01,4.486E-01,8.424E-01,2,"MHC class II, Bcl-2",
582,Development_Role of growth factors in the maintenance of embryonic stem cell pluripotency,53,4.486E-01,8.424E-01,4.486E-01,8.424E-01,2,"SOX2, FGFR1",
583,Notch signaling in breast cancer,53,4.486E-01,8.424E-01,4.486E-01,8.424E-01,2,"ESR1 (nuclear), TFF1",
584,Immune response_Inhibitory PD-1 signaling in T cells,53,4.486E-01,8.424E-01,4.486E-01,8.424E-01,2,"GATA-3, MHC class II",
585,Signal transduction_CXCR4 signaling via MAPKs cascades,53,4.486E-01,8.424E-01,4.486E-01,8.424E-01,2,"p38 MAPK, PREX1",
586,Role of prenatal nicotine exposure in inhibition of pancreatic beta cells differentiation and function,21,4.555E-01,8.424E-01,4.555E-01,8.424E-01,1,Kir6.2,
587,Development_Role of HGF in hematopoietic stem cell mobilization,21,4.555E-01,8.424E-01,4.555E-01,8.424E-01,1,G-CSF,
588,Nicotine signaling (general schema),21,4.555E-01,8.424E-01,4.555E-01,8.424E-01,1,nAChR alpha-4,
589,Inflammatory response in ischemia-reperfusion injury during myocardial infarction,21,4.555E-01,8.424E-01,4.555E-01,8.424E-01,1,IL8RA,
590,Possible regulation of HSF-1/ chaperone pathway in Huntington's disease,21,4.555E-01,8.424E-01,4.555E-01,8.424E-01,1,PLA2,
591,Multiple sclerosis (general schema),21,4.555E-01,8.424E-01,4.555E-01,8.424E-01,1,Transthyretin,
592,Inhibition of tumor suppressive pathways in pancreatic cancer,21,4.555E-01,8.424E-01,4.555E-01,8.424E-01,1,Rb protein,
593,Cell cycle_Cell cycle (generic schema),21,4.555E-01,8.424E-01,4.555E-01,8.424E-01,1,Rb protein,
594,Gamma-secretase regulation of mammary cell development,21,4.555E-01,8.424E-01,4.555E-01,8.424E-01,1,MTG16 (CBFA2T3),
595,Development_FGFR signaling pathway,54,4.582E-01,8.424E-01,4.582E-01,8.424E-01,2,"p38 MAPK, FGFR1",
596,Immune response_HSP60 and HSP70/ TLR signaling pathway,54,4.582E-01,8.424E-01,4.582E-01,8.424E-01,2,"MHC class II, p38 MAPK",
597,Membrane-bound ESR1: interaction with G-proteins signaling,54,4.582E-01,8.424E-01,4.582E-01,8.424E-01,2,"ESR1 (membrane), Adenylate cyclase",
598,Role of IL-23/ T17 pathogenic axis in psoriasis,54,4.582E-01,8.424E-01,4.582E-01,8.424E-01,2,"STAT3, MHC class II",
599,Impaired inhibitory action of lipoxins on ROS production in neutrophils in CF,54,4.582E-01,8.424E-01,4.582E-01,8.424E-01,2,"IL8RA, PREX1",
600,Growth factors in regulation of oligodendrocyte precursor cells proliferation in multiple sclerosis,54,4.582E-01,8.424E-01,4.582E-01,8.424E-01,2,"KV1.6, FGFR1",
601,PGE2 pathways in cancer,55,4.677E-01,8.476E-01,4.677E-01,8.476E-01,2,"Amphiregulin, Adenylate cyclase",
602,Development_WNT/Beta-catenin signaling in the cytoplasm,55,4.677E-01,8.476E-01,4.677E-01,8.476E-01,2,"p38alpha (MAPK14), Hck",
603,"Immune response_T cell co-signaling receptors, schema",55,4.677E-01,8.476E-01,4.677E-01,8.476E-01,2,"MHC class II, Collagen II",
604,Expression targets of Tissue factor signaling in cancer,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,Coagulation factor VII,
605,PXR signaling via cross-talk / Rodent version,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,PXR,
606,Differences between Langerhans cells and dermal dendritic cells in allergic contact dermatitis,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,MHC class II,
607,Inhibition of GSK3 beta by lithium in major depressive disorder,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,Bcl-2,
608,Immune response_Oncostatin M signaling via JAK-Stat,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,STAT3,
609,PXR signaling via cross-talk / Human Version,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,PXR,
610,Cell cycle_Role of 14-3-3 proteins in cell cycle regulation,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,p38 MAPK,
611,Development_Mu-type opioid receptor signaling via Beta-arrestin,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,STAT3,
612,Origin of Langerhans cells in the steady-state and under inflammatory conditions,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,CXCL14,
613,Inhibition of RUNX3 signaling in gastric cancer,22,4.710E-01,8.476E-01,4.710E-01,8.476E-01,1,Bcl-2,
614,Platelet activation as a result of endothelial dysfunction after stenting,56,4.771E-01,8.530E-01,4.771E-01,8.530E-01,2,"Adenylate cyclase, Glycoprotein VI",
615,Regulation of Beta-catenin activity in colorectal cancer,56,4.771E-01,8.530E-01,4.771E-01,8.530E-01,2,"PDCD4, Adenylate cyclase",
616,Airway smooth muscle contraction in asthma,56,4.771E-01,8.530E-01,4.771E-01,8.530E-01,2,"Adenylate cyclase, MLCK",
617,Nicotine metabolism in liver,56,4.771E-01,8.530E-01,4.771E-01,8.530E-01,2,"CYP2A6, UGT2B10",
618,Interconnectivity between Folic acid and Fluorouracil pathways in gastric cancer,91,4.828E-01,8.557E-01,4.828E-01,8.557E-01,3,"ABCC11, SLC22A8, CYP2A6",
619,Putative roles of SETDB1 and PLU-1 in melanoma,23,4.861E-01,8.557E-01,4.861E-01,8.557E-01,1,Rb protein,
620,Role of alpha-V/ beta-6 integrin in colorectal cancer,23,4.861E-01,8.557E-01,4.861E-01,8.557E-01,1,Bcl-2,
621,KLF6 and regulation of KLF6 alternative splicing in HCC,23,4.861E-01,8.557E-01,4.861E-01,8.557E-01,1,Rb protein,
622,Apoptosis and survival_NO signaling in apoptosis,23,4.861E-01,8.557E-01,4.861E-01,8.557E-01,1,p38 MAPK,
623,Role of IL-17-producing T cells in allergic contact dermatitis,23,4.861E-01,8.557E-01,4.861E-01,8.557E-01,1,MHC class II,
624,Development_Cytokine-mediated regulation of megakaryopoiesis,57,4.864E-01,8.557E-01,4.864E-01,8.557E-01,2,"STAT3, FLT3",
625,MicroRNAs in melanoma,57,4.864E-01,8.557E-01,4.864E-01,8.557E-01,2,"MaxiK alpha subunit, ZNF145",
626,Regulation of intrinsic membrane properties and excitability of striatopallidal medium spiny neurons in Huntington's disease,57,4.864E-01,8.557E-01,4.864E-01,8.557E-01,2,"MaxiK alpha subunit, CACNA1D",
627,Lysophospholipid mediators-induced inflammatory signaling in normal and asthmatic airway epithelium,57,4.864E-01,8.557E-01,4.864E-01,8.557E-01,2,"IL13RA2, p38 MAPK",
628,Immune response_IL-15 signaling,58,4.956E-01,8.658E-01,4.956E-01,8.658E-01,2,"p38 MAPK, Bcl-2",
629,"Immune response_TLR5, TLR7, TLR8 and TLR9 signaling pathways",58,4.956E-01,8.658E-01,4.956E-01,8.658E-01,2,"STAT3, p38 MAPK",
630,NMDA-independent presynaptic long-term potentiation in Huntington's disease,58,4.956E-01,8.658E-01,4.956E-01,8.658E-01,2,"GluR5, GluR7",
631,Dual role of TGF-beta 1 in HCC ,24,5.008E-01,8.658E-01,5.008E-01,8.658E-01,1,Bcl-2,
632,Hedgehog signaling in breast cancer,24,5.008E-01,8.658E-01,5.008E-01,8.658E-01,1,Rb protein,
633,Tissue factor signaling in lung cancer,24,5.008E-01,8.658E-01,5.008E-01,8.658E-01,1,Coagulation factor VII,
634,Mitochondrial ketone bodies biosynthesis and metabolism,24,5.008E-01,8.658E-01,5.008E-01,8.658E-01,1,HMGCS2,
635,Proteolysis_Role of Parkin in the Ubiquitin-Proteasomal Pathway,24,5.008E-01,8.658E-01,5.008E-01,8.658E-01,1,Tubulin alpha,
636,Apoptosis and survival_NO signaling in survival,24,5.008E-01,8.658E-01,5.008E-01,8.658E-01,1,p38 MAPK,
637,Immune response_IL-27 signaling pathway,24,5.008E-01,8.658E-01,5.008E-01,8.658E-01,1,STAT3,
638,Huntingtin-depended transcription deregulation in Huntington's Disease,24,5.008E-01,8.658E-01,5.008E-01,8.658E-01,1,C/EBPalpha,
639,Immune response_IFN-alpha/beta signaling via PI3K and NF-kB pathways,94,5.044E-01,8.661E-01,5.044E-01,8.661E-01,3,"STAT3, Rb protein, PDCD4",
640,Oxidative stress_Activation of NADPH oxidase,59,5.047E-01,8.661E-01,5.047E-01,8.661E-01,2,"p38 MAPK, PREX1",
641,Inhibition of apoptosis in pancreatic cancer,59,5.047E-01,8.661E-01,5.047E-01,8.661E-01,2,"STAT3, Bcl-2",
642,Cigarette smoke-induced oxidative stress and apoptosis in airway epithelial cells,60,5.137E-01,8.661E-01,5.137E-01,8.661E-01,2,"p38 MAPK, Bcl-2",
643,Apoptosis and survival_TNF-alpha-induced ROS-dependent Caspase-3 signaling,60,5.137E-01,8.661E-01,5.137E-01,8.661E-01,2,"p38alpha (MAPK14), Bcl-2",
644,Development_Regulation of endothelial progenitor cell differentiation from adult stem cells,60,5.137E-01,8.661E-01,5.137E-01,8.661E-01,2,"G-CSF, Epo",
645,Immune escape mechanisms in Prostate Cancer,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,CCL17,
646,Putative pathways of activation of monoclonal protein secretion in multiple myeloma,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,XBP1,
647,IGF-1 receptor/EGFR cooperation in lung cancer,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,Amphiregulin,
648,Immune response_LPS-induced platelet activation,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,Glycoprotein VI,
649,Role of keratinocytes and Langerhans cells in skin sensitization,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,MHC class II,
650,Generation of cytotoxic CD8+ T cells in COPD,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,MHC class II,
651,G-protein signaling_K-RAS regulation pathway,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,Epo,
652,Immune response_T cell subsets: secreted signals,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,Amphiregulin,
653,HSP70 and HSP40-dependent folding in Huntington's disease,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,HSP22,
654,T cell generation in COPD,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,MHC class II,
655,Dual role of BMP signaling in gastric cancer,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,Mucin 2,
656,Inhibition of TGF-beta signaling in gastric cancer,25,5.151E-01,8.661E-01,5.151E-01,8.661E-01,1,CEACAM5,
657,n-6 Polyunsaturated fatty acid biosynthesis,61,5.226E-01,8.706E-01,5.226E-01,8.706E-01,2,"ELOVL2, ACOX2",
658,Hedgehog signaling in prostate cancer,26,5.289E-01,8.706E-01,5.289E-01,8.706E-01,1,Bcl-2,
659,Neurophysiological process_GABA-B receptor signaling at postsynaptic sides of synapses,26,5.289E-01,8.706E-01,5.289E-01,8.706E-01,1,Kir3.1,
660,CREB1-dependent transcription deregulation in Huntington's Disease,26,5.289E-01,8.706E-01,5.289E-01,8.706E-01,1,Bcl-2,
661,Neurophysiological process_Dopamine D2 receptor transactivation of PDGFR in CNS,26,5.289E-01,8.706E-01,5.289E-01,8.706E-01,1,PP2A regulatory,
662,CAR signaling via cross-talk / Human Version,26,5.289E-01,8.706E-01,5.289E-01,8.706E-01,1,ESR1 (nuclear),
663,"SREBP1 cross-talk with PXR, CAR and LXR",26,5.289E-01,8.706E-01,5.289E-01,8.706E-01,1,PXR,
664,CD8+ Tc1 cells in allergic contact dermatitis,26,5.289E-01,8.706E-01,5.289E-01,8.706E-01,1,MHC class II,
665,Glucocorticoid-induced elevation of intraocular pressure as glaucoma risk factor,62,5.313E-01,8.706E-01,5.313E-01,8.706E-01,2,"MLCK, FGFR1",
666,Development_Gastrin in cell growth and proliferation,62,5.313E-01,8.706E-01,5.313E-01,8.706E-01,2,"STAT3, p38alpha (MAPK14)",
667,Immune response_IL-18 signaling,63,5.400E-01,8.706E-01,5.400E-01,8.706E-01,2,"p38 MAPK, Bcl-2",
668,Transcription_PPAR Pathway,63,5.400E-01,8.706E-01,5.400E-01,8.706E-01,2,"p38alpha (MAPK14), p38 MAPK",
669,Degranulation of lung mast cells,63,5.400E-01,8.706E-01,5.400E-01,8.706E-01,2,"Tryptase, PGE2R3",
670,n-3 Polyunsaturated fatty acid biosynthesis,63,5.400E-01,8.706E-01,5.400E-01,8.706E-01,2,"ELOVL2, ACOX2",
671,G-protein signaling_G-Protein alpha-i signaling cascades,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,STAT3,
672,Development_Generation of pancreatic beta-cells from induced pluripotent stem cells,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,SOX2,
673,"N-Acylethanolamines, HSRL5-transacylation pathway",27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,HRSL5,
674,Inhibition of TGF-beta 1 signaling in early colorectal cancer,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,CEACAM5,
675,HCV-dependent cytoplasmic signaling leading to HCC,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,p38 MAPK,
676,Desensitization of Beta-2 adrenergic receptor signaling and reduction of relaxation,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,PGE2R3,
677,CAR signaling via cross-talk / Rodent version,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,ESR1 (nuclear),
678,Regulation of VEGF signaling in pancreatic cancer,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,STAT3,
679,Histamine metabolism,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,ABP1,
680,Neurophysiological process_GABA-A receptor life cycle,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,GABA-A receptor gamma-2 subunit,
681,Regulatory T cells in murine model of contact hypersensitivity,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,MHC class II,
682,Triacylglycerol metabolism p.2,27,5.424E-01,8.706E-01,5.424E-01,8.706E-01,1,LIPG,
683,Main chemotherapy drugs and their action in SCLC cells,100,5.463E-01,8.706E-01,5.463E-01,8.706E-01,3,"p38alpha (MAPK14), p38 MAPK, Bcl-2",
684,Development_Regulation of epithelial-to-mesenchymal transition (EMT),64,5.485E-01,8.706E-01,5.485E-01,8.706E-01,2,"FGFR1, Bcl-2",
685,Immune response_IFN-alpha/beta signaling via JAK/STAT,64,5.485E-01,8.706E-01,5.485E-01,8.706E-01,2,"STAT3, Bcl-2",
686,Folic acid metabolism,64,5.485E-01,8.706E-01,5.485E-01,8.706E-01,2,"FR-beta, FTDH",
687,Neurophysiological process_GABA-B receptor signaling in presynaptic nerve terminals,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,Adenylate cyclase type V,
688,Cell cycle_Regulation of G1/S transition (part 2),28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,Rb protein,
689,Mitogenic action of Estradiol / ESR1 (nuclear) in breast cancer,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,ESR1 (nuclear),
690,Development_Regulation of CDK5 in CNS,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,Adenylate cyclase type V,
691,DNA damage_ATM / ATR regulation of G2 / M checkpoint,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,p38alpha (MAPK14),
692,Development_Role of CNTF and LIF in regulation of oligodendrocyte development,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,STAT3,
693,Tumor-stroma interactions in pancreatic cancer,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,FGFR1,
694,Release of pro-inflammatory mediators and elastolytic enzymes by alveolar macrophages in COPD,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,p38 MAPK,
695,Development_Astrocyte differentiation (general schema),28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,STAT3,
696,The role of aberrations in CDKN2 locus and CDK4 in familial melanoma,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,Rb protein,
697,Pro-oncogenic action of Androgen receptor in ovarian cancer,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,Androgen receptor,
698,Development_Delta-type opioid receptor signaling via G-protein alpha-14,28,5.555E-01,8.706E-01,5.555E-01,8.706E-01,1,STAT3,
699,Immune response_CD40 signaling,65,5.570E-01,8.706E-01,5.570E-01,8.706E-01,2,"STAT3, p38 MAPK",
700,Ovarian cancer (main signaling cascades),65,5.570E-01,8.706E-01,5.570E-01,8.706E-01,2,"Androgen receptor, ESR1 (nuclear)",
701,Role of Tissue factor-induced Thrombin signaling in cancerogenesis,65,5.570E-01,8.706E-01,5.570E-01,8.706E-01,2,"Coagulation factor VII, MLCK",
702,Renal tubulointerstitial injury in Lupus Nephritis ,65,5.570E-01,8.706E-01,5.570E-01,8.706E-01,2,"MHC class II, CCR5",
703,Signal transduction_PDGF signaling via JAK-STAT and reactive oxygen species (ROS),66,5.653E-01,8.706E-01,5.653E-01,8.706E-01,2,"STAT3, Bcl-2",
704,Hedgehog signaling in gastric cancer,29,5.682E-01,8.706E-01,5.682E-01,8.706E-01,1,Islet-1,
705,Pro-oncogenic action of PTHrP in breast cancer,29,5.682E-01,8.706E-01,5.682E-01,8.706E-01,1,Bcl-2,
706,Suppression of TGF-beta signaling in pancreatic cancer,29,5.682E-01,8.706E-01,5.682E-01,8.706E-01,1,p38 MAPK,
707,Cholesterol and Sphingolipid transport / Recycling to plasma membrane in lung (normal and CF),29,5.682E-01,8.706E-01,5.682E-01,8.706E-01,1,ABCG1,
708,Abnormalities in cell cycle in SCLC,29,5.682E-01,8.706E-01,5.682E-01,8.706E-01,1,Rb protein,
709,EZH2 in Prostate Cancer,29,5.682E-01,8.706E-01,5.682E-01,8.706E-01,1,PGE2R3,
710,Prostate Cancer: candidate susceptibility genes in inflammatory pathways,29,5.682E-01,8.706E-01,5.682E-01,8.706E-01,1,IL8RA,
711,Eosinophil survival in asthma,67,5.735E-01,8.706E-01,5.735E-01,8.706E-01,2,"p38 MAPK, Bcl-2",
712,ErbB2-induced breast cancer cell invasion,67,5.735E-01,8.706E-01,5.735E-01,8.706E-01,2,"PDCD4, p38 MAPK",
713,Role of neuropeptides in pathogenesis of SCLC,67,5.735E-01,8.706E-01,5.735E-01,8.706E-01,2,"CCK8, GRP-R",
714,B-regulatory cells and tumor cells intercellular interaction,67,5.735E-01,8.706E-01,5.735E-01,8.706E-01,2,"STAT3, p38 MAPK",
715,Development_Growth factors in regulation of oligodendrocyte progenitor cell proliferation,67,5.735E-01,8.706E-01,5.735E-01,8.706E-01,2,"KV1.6, FGFR1",
716,Muscle contraction_S1P2 receptor-mediated smooth muscle contraction,30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,MLCK,
717,"Regulation of lipid metabolism_RXR-dependent regulation of lipid metabolism via PPAR, RAR and VDR",30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,HMGCS2,
718,Cell adhesion_Gap junctions,30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,Tubulin alpha,
719,Fatty Acid Omega Oxidation,30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,ADH7,
720,"Immune response_Mast cell proliferation, differentiation and survival",30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,STAT3,
721,Inhibition of mast cell functions by Fc gamma RII beta in asthma,30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,Fc gamma RII beta,
722,Role of CNTF and LIF in regulation of oligodendrocyte development in multiple sclerosis,30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,STAT3,
723,Inter-cellular relations in COPD (general schema),30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,IL8RB,
724,Activation of TGF-beta signaling in advanced colorectal cancer,30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,p38 MAPK,
725,Putative role of Tregs in COPD,30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,STAT3,
726,L-Carnitine biosynthesis,30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,SLC22A8,
727,Production of arachidonic acid derivatives by mast cells in asthma,30,5.805E-01,8.706E-01,5.805E-01,8.706E-01,1,PLA2G2D,
728,Signal transduction_mTORC2 downstream signaling,68,5.816E-01,8.706E-01,5.816E-01,8.706E-01,2,"SLC12A1, PREX1",
729,Production of reactive oxygen species and arachidonic acid metabolites by neutrophils in asthma,68,5.816E-01,8.706E-01,5.816E-01,8.706E-01,2,"IL8RA, p38 MAPK",
730,Immune response_TLR2 and TLR4 signaling pathways,69,5.896E-01,8.706E-01,5.896E-01,8.706E-01,2,"Hck, p38 MAPK",
731,Role of microRNAs in cell proliferation in colorectal cancer,69,5.896E-01,8.706E-01,5.896E-01,8.706E-01,2,"Rb protein, RhoB",
732,Sphingolipid metabolism,107,5.923E-01,8.706E-01,5.923E-01,8.706E-01,3,"ACER1, GM3 synthase, DEGS2",
733,Deregulation of canonical WNT signaling in major depressive disorder,31,5.925E-01,8.706E-01,5.925E-01,8.706E-01,1,Tau (MAPT),
734,SHH signaling in colorectal cancer,31,5.925E-01,8.706E-01,5.925E-01,8.706E-01,1,Bcl-2,
735,Development_Inhibition of angiogenesis by PEDF,31,5.925E-01,8.706E-01,5.925E-01,8.706E-01,1,p38 MAPK,
736,Linoleic acid metabolism,31,5.925E-01,8.706E-01,5.925E-01,8.706E-01,1,ALOX15B,
737,"SREBP1 cross-talk with PXR, CAR and LXR/ Rodent version",31,5.925E-01,8.706E-01,5.925E-01,8.706E-01,1,PXR,
738,Fibroblast differentiation to myofibroblasts in asthmatic airways,31,5.925E-01,8.706E-01,5.925E-01,8.706E-01,1,p38 MAPK,
739,Mechanisms of K-RAS addiction in lung cancer cells,31,5.925E-01,8.706E-01,5.925E-01,8.706E-01,1,Bcl-2,
740,Immune response_IL-23 signaling pathway,31,5.925E-01,8.706E-01,5.925E-01,8.706E-01,1,STAT3,
741,Tyrosine metabolism p.1 (dopamine) ,70,5.975E-01,8.706E-01,5.975E-01,8.706E-01,2,"TY3H, ABP1",
742,Retinol metabolism,70,5.975E-01,8.706E-01,5.975E-01,8.706E-01,2,"CYP2A6, Rhodopsin",
743,"Stem cells_Cooperation between Hedgehog, IGF-2 and HGF signaling pathways in medulloblastoma stem cells",32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,Bcl-2,
744,Cell cycle_Role of Nek in cell cycle regulation,32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,Tubulin alpha,
745,Epithelial cell apoptosis in COPD,32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,Bcl-2,
746,"Development_Role of Ceramide 1-phosphate, Sphingosine 1-phosphate and Complement cascade in hematopoietic stem cell homing",32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,PGE2R3,
747,Interleukins-induced inflammatory signaling in normal and asthmatic airway epithelium,32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,p38 MAPK,
748,Stem cells_Role of ion channels in glioblastoma cell invasion,32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,MaxiK alpha subunit,
749,Hedgehog signaling in pancreatic cancer,32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,Bcl-2,
750,Protein folding and maturation_Bradykinin / Kallidin maturation,32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,Tissue kallikreins,
751,Activation of ACTH production in pituitary gland in major depressive disorder,32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,STAT3,
752,Development_H3K4 demethylases in stem cell maintenance,32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,FGF4,
753,Apoptosis and survival_IL-17-induced CIKS-dependent MAPK signaling pathways,32,6.041E-01,8.706E-01,6.041E-01,8.706E-01,1,p38 MAPK,
754,Immune response_IL-6 signaling pathway via JAK/STAT,71,6.052E-01,8.706E-01,6.052E-01,8.706E-01,2,"STAT3, CISH",
755,Blood coagulation_GPCRs in platelet aggregation,71,6.052E-01,8.706E-01,6.052E-01,8.706E-01,2,"Alpha-2A adrenergic receptor, Adenylate cyclase",
756,Signal transduction_Adenosine A2B receptor signaling pathway,71,6.052E-01,8.706E-01,6.052E-01,8.706E-01,2,"p38 MAPK, Adenylate cyclase",
757,Angiotensin II Signaling in Cardiac Hypertrophy,72,6.129E-01,8.706E-01,6.129E-01,8.706E-01,2,"Kv4.3 channel, p38 MAPK",
758,Blood coagulation_Platelet microparticle generation,72,6.129E-01,8.706E-01,6.129E-01,8.706E-01,2,"Alpha-2A adrenergic receptor, Glycoprotein VI",
759,G-protein signaling_Regulation of CDC42 activity,33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,FGFR1,
760,Role of metalloproteases and heparanase in progression of pancreatic cancer,33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,Alpha 1-antitrypsin,
761,G-protein signaling_N-RAS regulation pathway,33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,MHC class II,
762,p53 signaling in Prostate Cancer,33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,Androgen receptor,
763,"IGF family, invasion and metastasis in colorectal cancer",33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,p38 MAPK,
764,Apoptosis and survival_Regulation of Apoptosis by Mitochondrial Proteins,33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,Bcl-2,
765,Cell cycle_Spindle assembly and chromosome separation,33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,Tubulin alpha,
766,Normal and pathological TGF-beta-mediated regulation of cell proliferation,33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,p38 MAPK,
767,Development_Role of PKR1 and ILK in cardiac progenitor cells,33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,Islet-1,
768,Signal transduction_Activin A signaling regulation,33,6.155E-01,8.706E-01,6.155E-01,8.706E-01,1,Inhibin alpha subunit,
769,Aspartate and asparagine metabolism,73,6.204E-01,8.706E-01,6.204E-01,8.706E-01,2,"GABT, CPSM",
770,Disruption of epithelial layer restitution in asthma,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,RXRG,
771,Nicotine / Beta-adrenergic signaling in lung cancer,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,Adenylate cyclase,
772,Regulation of CFTR gating (normal and CF),34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,Adenylate cyclase,
773,Mechanism of action of CCR4 antagonists in asthma and atopic dermatitis (Variant 1),34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,CCL17,
774,CCR4-dependent immune cell chemotaxis in asthma and atopic dermatitis ,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,CCL17,
775,Apoptosis and survival_Role of CDK5 in neuronal death and survival,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,Bcl-2,
776,Development_Histone acetylation in embryonic stem cells,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,SOX2,
777,Role of Apo-2L(TNFSF10) in Prostate Cancer cell apoptosis,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,Bcl-2,
778,Development_CNTF receptor signaling,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,STAT3,
779,Chemotaxis_CCR4-induced chemotaxis of immune cells,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,CCL17,
780,Cannabinoid receptor signaling in nicotine addiction,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,nAChR alpha-4,
781,"Apoptosis and survival_Cytoplasmic/mitochondrial transport of proapoptotic proteins Bid, Bmf and Bim",34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,Bcl-2,
782,Role of IFN-beta in inhibition of Th1 cell differentiation in multiple sclerosis,34,6.264E-01,8.706E-01,6.264E-01,8.706E-01,1,MHC class II,
783,L-Phenylalanine metabolism,74,6.278E-01,8.706E-01,6.278E-01,8.706E-01,2,"SLC7A8, GLYATL1",
784,Immune response_IL-6 signaling pathway via MEK/ERK and PI3K/AKT cascades,74,6.278E-01,8.706E-01,6.278E-01,8.706E-01,2,"STAT3, Hck",
785,Catecholamine metabolism,75,6.351E-01,8.706E-01,6.351E-01,8.706E-01,2,"TY3H, SULT1A1",
786,Role of osteoblasts in bone lesions formation in multiple myeloma,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,CCR5,
787,Production and activation of TGF-beta in airway smooth muscle cells,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,Tryptase,
788,G-protein signaling_S1P2 receptor signaling pathway,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,Adenylate cyclase,
789,Autophagy_Autophagy,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,Bcl-2,
790,Development_Angiopoietin - Tie2 signaling,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,STAT3,
791,Altered Ca2+ handling in heart failure,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,Adenylate cyclase,
792,NF-kB pathway in multiple myeloma,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,Bcl-2,
793,Th2 cytokine- and TNF-alpha-induced inflammatory response in asthmatic airway fibroblasts,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,G-CSF,
794,Anti-apoptotic action of Gastrin in gastric cancer,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,Bcl-2,
795,Estrone metabolism,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,HSD17B1,
796,Mechanisms of CAM-DR in multiple myeloma,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,STAT3,
797,Immune response_TLR ligands,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,SP-A,
798,Extracellular matrix-regulated proliferation of airway smooth muscle cells in asthma,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,p38 MAPK,
799,Keratan sulfate metabolism p.1,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,CHST1,
800,Langerhans cell migration to lymph nodes in allergic contact dermatitis,35,6.371E-01,8.706E-01,6.371E-01,8.706E-01,1,CCL17,
801,"Signal transduction_Angiotensin II/AGTR1 signaling via Notch, Beta-catenin and NF-kB pathways",76,6.423E-01,8.706E-01,6.423E-01,8.706E-01,2,"p38 MAPK, YAP1 (YAp65)",
802,"Immune response_IL-5 signaling via PI3K, MAPK and NF-kB",76,6.423E-01,8.706E-01,6.423E-01,8.706E-01,2,"Fc gamma RII beta, p38 MAPK",
803,IGF-1 signaling in pancreatic cancer,36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,STAT3,
804,Cigarette smoke components TCDD and Benzo[a]pyrene and receptor AHR signaling in lung epithelial cells,36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,Mucin 5AC,
805,Higher ESR1 / ESR2 ratio in breast cancer,36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,ESR1 (nuclear),
806,G-protein signaling_Rac2 regulation pathway,36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,PREX1,
807,Endothelial cell apoptosis in COPD,36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,Bcl-2,
808,HBV signaling via protein kinases leading to HCC,36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,Androgen receptor,
809,Immune response_HMGB1/TLR signaling pathway,36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,p38alpha (MAPK14),
810,Development_Hedgehog and PTH signaling pathways in bone and cartilage development,36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,Bone sialoprotein,
811,"Development_Lipoxin inhibitory action on PDGF, EGF and LTD4 signaling",36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,Adenylate cyclase,
812,CHDI_Correlations from Discovery data_Causal network (positive),36,6.475E-01,8.706E-01,6.475E-01,8.706E-01,1,STAT3,
813,Blood coagulation_GPIb-IX-V-dependent platelet activation,77,6.494E-01,8.706E-01,6.494E-01,8.706E-01,2,"p38alpha (MAPK14), Glycoprotein VI",
814,Immune response_IFN-alpha/beta signaling via MAPKs,77,6.494E-01,8.706E-01,6.494E-01,8.706E-01,2,"ZNF145, p38 MAPK",
815,Development_Growth factors in regulation of oligodendrocyte precursor cell survival,37,6.576E-01,8.706E-01,6.576E-01,8.706E-01,1,Bcl-2,
816,FGFR3 signaling in multiple myeloma,37,6.576E-01,8.706E-01,6.576E-01,8.706E-01,1,STAT3,
817,Development_Negative feedback regulation of WNT/Beta-catenin signaling,37,6.576E-01,8.706E-01,6.576E-01,8.706E-01,1,ZNF703,
818,G-protein signaling_Regulation of p38 and JNK signaling mediated by G-proteins,37,6.576E-01,8.706E-01,6.576E-01,8.706E-01,1,p38 MAPK,
819,A shift in alveolar macrophage phenotype in COPD,37,6.576E-01,8.706E-01,6.576E-01,8.706E-01,1,MHC class II,
820,Immune response_Oncostatin M signaling via MAPK,37,6.576E-01,8.706E-01,6.576E-01,8.706E-01,1,p38 MAPK,
821,"Leucine, isoleucine and valine metabolism.p.2",79,6.632E-01,8.706E-01,6.632E-01,8.706E-01,2,"GABT, HMGCS2",
822,CHDI_Correlations from Replication data_Causal network (positive correlations),79,6.632E-01,8.706E-01,6.632E-01,8.706E-01,2,"MHC class II, p38 MAPK",
823,L-Arginine metabolism,79,6.632E-01,8.706E-01,6.632E-01,8.706E-01,2,"CPSM, ABP1",
824,G-protein signaling_G-Protein alpha-12 signaling pathway,38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,p38 MAPK,
825,Activation of Ca2+-dependent neuronal cell death in Huntington's disease,38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,p38 MAPK,
826,Cell cycle_Regulation of G1/S transition (part 1),38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,PP2A regulatory,
827,Immune response_Role of integrins in NK cells cytotoxicity,38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,p38 MAPK,
828,Insulin-like growth factor family signaling in melanoma,38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,p38 MAPK,
829,wtCFTR and deltaF508-CFTR traffic / Generic schema (normal and CF),38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,EBP50,
830,HDL dyslipidemia in type 2 diabetes and metabolic syndrome X,38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,ABCG1,
831,Development_Oligodendrocyte differentiation (general schema),38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,OLIG1,
832,Development_Neural stem cell lineage commitment (schema),38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,ATP1A2,
833,IgE-dependent production of pro-inflammatory mediators by neutrophils in asthma,38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,p38 MAPK,
834,Role of type 2 innate lymphoid cells in asthma,38,6.674E-01,8.706E-01,6.674E-01,8.706E-01,1,GATA-3,
835,L-Tryptophan metabolism (part 1),80,6.699E-01,8.706E-01,6.699E-01,8.706E-01,2,"SLC7A8, TDO2",
836,B cell signaling in hematological malignancies,80,6.699E-01,8.706E-01,6.699E-01,8.706E-01,2,"STAT3, Bcl-2",
837,Immune response_M-CSF-receptor signaling pathway,81,6.766E-01,8.706E-01,6.766E-01,8.706E-01,2,"STAT3, Hck",
838,Fructose metabolism,81,6.766E-01,8.706E-01,6.766E-01,8.706E-01,2,"SUIS, F16P",
839,Atorvastatin in treatment of type 2 diabetes and metabolic syndrome X,39,6.769E-01,8.706E-01,6.769E-01,8.706E-01,1,OATP-C,
840,HGF signaling in melanoma,39,6.769E-01,8.706E-01,6.769E-01,8.706E-01,1,p38 MAPK,
841,Role of neurotrophins in activation of p53 in major depressive disorder,39,6.769E-01,8.706E-01,6.769E-01,8.706E-01,1,Bcl-2,
842,Keratan sulfate metabolism p.2,39,6.769E-01,8.706E-01,6.769E-01,8.706E-01,1,CHST1,
843,Role of iNKT and B cells in T cell recruitment in allergic contact dermatitis,39,6.769E-01,8.706E-01,6.769E-01,8.706E-01,1,AID,
844,"VLDL, LDL dyslipidemia in type 2 diabetes and metabolic syndrome X",39,6.769E-01,8.706E-01,6.769E-01,8.706E-01,1,APOB48 receptor,
845,Nicotine signaling in GABAergic neurons,39,6.769E-01,8.706E-01,6.769E-01,8.706E-01,1,nAChR alpha-4,
846,Apoptosis and survival_APRIL and BAFF signaling,39,6.769E-01,8.706E-01,6.769E-01,8.706E-01,1,Bcl-2,
847,Immune response_IL-1 signaling pathway,82,6.831E-01,8.706E-01,6.831E-01,8.706E-01,2,"p38alpha (MAPK14), Collagen II",
848,Androgen biosynthetic pathways,82,6.831E-01,8.706E-01,6.831E-01,8.706E-01,2,"AKR1C4, HSD17B1",
849,Neurophysiological process_Delta-type opioid receptor in the nervous system,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,Adenylate cyclase type II,
850,Activation of Cortisol production in major depressive disorder,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,Adenylate cyclase type V,
851,Development_Role of Activin A in cell differentiation and proliferation,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,Adenylate cyclase,
852,Apoptosis and survival_Ceramides signaling pathway,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,Bcl-2,
853,Memory CD8+ T cells in allergic contact dermatitis,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,CCL17,
854,Development_FGF2-induced self-renewal of adult neural stem cells,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,FGFR1,
855,Development_SLIT-ROBO1 signaling,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,PREX1,
856,Role of glycosphingolipids in inhibition of Insulin signaling,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,GM3 synthase,
857,Role of IGH translocations in multiple myeloma,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,Rb protein,
858,Apoptosis and survival_NGF activation of NF-kB,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,Bcl-2,
859,CAR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,CYP2A6,
860,Role of Ghrelin in activation eating behavior in obesity,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,Adenylate cyclase type II,
861,Stem cells_Response to hypoxia in glioblastoma stem cells,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,BMP7,
862,Stem cells_Pancreatic cancer stem cells in tumor metastasis,40,6.861E-01,8.706E-01,6.861E-01,8.706E-01,1,MLCK,
863,Role of Bregs in attenuation of T and NK cells mediated anti-tumor immune responses,41,6.951E-01,8.706E-01,6.951E-01,8.706E-01,1,STAT3,
864,Main growth factor signaling cascades in multiple myeloma cells,41,6.951E-01,8.706E-01,6.951E-01,8.706E-01,1,STAT3,
865,Development_Oxytocin receptor signaling,41,6.951E-01,8.706E-01,6.951E-01,8.706E-01,1,MYOG,
866,Pro-tumoral TNF-alpha signaling in melanoma,41,6.951E-01,8.706E-01,6.951E-01,8.706E-01,1,IL8RB,
867,Possible pathway of TGF-beta 1-dependent inhibition of CFTR expression,41,6.951E-01,8.706E-01,6.951E-01,8.706E-01,1,p38 MAPK,
868,Apoptosis and survival_Phosphorylation and acetylation in TNF-alpha-induced NF-kB signaling,41,6.951E-01,8.706E-01,6.951E-01,8.706E-01,1,p38alpha (MAPK14),
869,Immune response_TLR2-induced platelet activation,41,6.951E-01,8.706E-01,6.951E-01,8.706E-01,1,p38 MAPK,
870,Apoptosis and survival_Phosphorylation in TNF-alpha-induced NF-kB signaling,41,6.951E-01,8.706E-01,6.951E-01,8.706E-01,1,Adenylate cyclase,
871,Apoptosis and survival_Apoptotic TNF-family pathways,42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,Bcl-2,
872,Apoptosis and survival_BAD phosphorylation,42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,Bcl-2,
873,Transport_ACM3 signaling in salivary glands,42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,MLCK,
874,Development_VEGF signaling and activation,42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,ESR1 (nuclear),
875,Inhibition of apoptosis in gastric cancer,42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,Bcl-2,
876,Transport_HDL-mediated reverse cholesterol transport,42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,ABCG1,
877,Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/Bcl-2 pathway,42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,Bcl-2,
878,Signal transduction_Angiotensin II/ AGTR1 signaling via TGF-beta 1 and SMADs,42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,p38 MAPK,
879,Estrogen biosynthesis,42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,HSD17B1,
880,"TNF-alpha, IL-1 beta induce dyslipidemia and inflammation in obesity and type 2 diabetes in adipocytes ",42,7.038E-01,8.706E-01,7.038E-01,8.706E-01,1,Perilipin,
881,Translation_Non-genomic (rapid) action of Androgen Receptor,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Androgen receptor,
882,Immune response_IL-7 signaling in B lymphocytes,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,STAT3,
883,"Nicotine signaling in dopaminergic neurons, Pt. 2 - axon terminal",43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Adenylate cyclase type V,
884,Cytoskeleton remodeling_Hyaluronic acid/ CD44 signaling pathways,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,MLCK,
885,Immune response_Antimicrobial actions of IFN-gamma,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,SLC26A3 (DRA),
886,Apoptosis and survival_Anti-apoptotic action of Gastrin,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Bcl-2,
887,Nicotine / nAChR alpha-7 signaling in NSCLC,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Rb protein,
888,Development_EPO-induced PI3K/AKT pathway and Ca(2+) influx,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Epo,
889,Role of platelets in the initiation of in-stent restenosis,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Glycoprotein VI,
890,Immune response_Substance P-stimulated expression of proinflammatory cytokines via MAPKs,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,p38 MAPK,
891,Development_S1P3 receptor signaling pathway,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Adenylate cyclase,
892,Development_Notch Signaling Pathway,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,MYOD,
893,Role of epigenetic alterations in survival and migration of SCLC cells,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Bcl-2,
894,Regulation of Tissue factor signaling in cancer,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Coagulation factor VII,
895,Apoptosis and survival_TNFR1 signaling pathway,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,Bcl-2,
896,Apoptosis and survival_TNF-alpha-induced Caspase-8 signaling,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,PP2A regulatory,
897,Regulation of immune cell differentiation by Notch signaling,43,7.123E-01,8.706E-01,7.123E-01,8.706E-01,1,GATA-3,
898,Cholesterol metabolism,87,7.141E-01,8.706E-01,7.141E-01,8.706E-01,2,"AKR1C4, ACOX2",
899,Impaired Lipoxin A4 signaling in CF,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,Adenylate cyclase,
900,TGF-beta 1-mediated induction of EMT in normal and asthmatic airway epithelium,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,p38 MAPK,
901,Role of TLR signaling in skin sensitization,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,p38 MAPK,
902,Thiamine metabolism,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,SLC44A4,
903,Proliferative action of Gastrin in pancreatic cancer,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,STAT3,
904,Apoptosis and survival_FAS signaling cascades,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,Bcl-2,
905,Role of mevalonate pathway in multiple myeloma,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,RhoB,
906,Immune response_CRTH2 signaling in Th2 cells,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,Adenylate cyclase,
907,Arachidonic acid metabolites production in eosinophils in asthma,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,p38 MAPK,
908,Leptin signaling in colorectal cancer,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,STAT3,
909,Development_S1P1 signaling pathway,44,7.205E-01,8.706E-01,7.205E-01,8.706E-01,1,Adenylate cyclase,
910,Development_Negative regulation of WNT/Beta-catenin signaling in the nucleus,89,7.258E-01,8.706E-01,7.258E-01,8.706E-01,2,"ZNF703, SOX2",
911,Apo-2L(TNFSF10)-induced apoptosis in melanoma,45,7.285E-01,8.706E-01,7.285E-01,8.706E-01,1,XBP1,
912,Development_Negative regulation of WNT/Beta-catenin signaling at the receptor level,45,7.285E-01,8.706E-01,7.285E-01,8.706E-01,1,Klotho,
913,Stem cells_Excitotoxicity of Glutamate in glioblastoma,45,7.285E-01,8.706E-01,7.285E-01,8.706E-01,1,SLC1A2/EAAT2,
914,SCAP/SREBP Transcriptional Control of Cholesterol and FA Biosynthesis,45,7.285E-01,8.706E-01,7.285E-01,8.706E-01,1,HMGCS2,
915,LKB1 signaling pathway in lung cancer cells,45,7.285E-01,8.706E-01,7.285E-01,8.706E-01,1,STAT3,
916,Development_EPO-induced MAPK pathway,45,7.285E-01,8.706E-01,7.285E-01,8.706E-01,1,Epo,
917,Cell adhesion_Histamine H1 receptor signaling in the interruption of cell barrier integrity,45,7.285E-01,8.706E-01,7.285E-01,8.706E-01,1,MLCK,
918,Signal transduction_Angiotensin II/ AGTR1 signaling via JAK/STAT,45,7.285E-01,8.706E-01,7.285E-01,8.706E-01,1,STAT3,
919,"Role of TNF-alpha, IL-1beta and IL-6 in development of obesity and type 2 diabetes in liver",45,7.285E-01,8.706E-01,7.285E-01,8.706E-01,1,STAT3,
920,T follicular helper cell dysfunction in SLE,90,7.315E-01,8.706E-01,7.315E-01,8.706E-01,2,"STAT3, MHC class II",
921,Glycine and L-Serine metabolism,133,7.355E-01,8.706E-01,7.355E-01,8.706E-01,3,"SLC7A8, GNMT, AGXT",
922,Niacin-HDL metabolism,46,7.363E-01,8.706E-01,7.363E-01,8.706E-01,1,HDL proteins,
923,Immune response_Inhibitory action of Lipoxins on pro-inflammatory TNF-alpha signaling,46,7.363E-01,8.706E-01,7.363E-01,8.706E-01,1,STAT3,
924,Anandamide biosynthesis and metabolism,46,7.363E-01,8.706E-01,7.363E-01,8.706E-01,1,HRSL5,
925,Dual function of Treg cells in cancer development,46,7.363E-01,8.706E-01,7.363E-01,8.706E-01,1,STAT3,
926,Glomerular injury in Lupus Nephritis,92,7.426E-01,8.706E-01,7.426E-01,8.706E-01,2,"p38 MAPK, Bcl-2",
927,Immune response_Induction of apoptosis and inhibition of proliferation mediated by IFN-gamma,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,Rb protein,
928,Immune response_Histamine H1 receptor signaling in immune response,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,p38 MAPK,
929,Development_Beta-adrenergic receptor-induced regulation of ERK,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,Adenylate cyclase,
930,Regulation of mast cell survival in asthma,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,Bcl-2,
931,Immune response_Fc gamma R-mediated phagocytosis in macrophages,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,Hck,
932,Canonical Notch signaling pathway in colorectal cancer,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,Mucin 2,
933,Development_HGF signaling pathway,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,STAT3,
934,Immune response_Role of DPP4 (CD26) in immune regulation,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,MHC class II,
935,Phospholipid metabolism p.2,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,HRSL5,
936,Regulation of lipid metabolism_PPAR regulation of lipid metabolism,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,Fatty acid-binding protein,
937,Neurophysiological process_Circadian rhythm,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,Dexras1,
938,Renal secretion of drugs / Rodent version ,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,SLC22A8,
939,Transport_GPR40 signaling pathway in beta cells,47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,CACNA1D,
940,wtCFTR and deltaF508 traffic / Membrane expression (normal and CF),47,7.438E-01,8.706E-01,7.438E-01,8.706E-01,1,EBP50,
941,L-Lysine metabolism,93,7.480E-01,8.706E-01,7.480E-01,8.706E-01,2,"CRYM, CAT-2",
942,Development_VEGF signaling via VEGFR2 - generic cascades,93,7.480E-01,8.706E-01,7.480E-01,8.706E-01,2,"p38 MAPK, MLCK",
943,Immune response_NF-AT signaling and leukocyte interactions,48,7.512E-01,8.706E-01,7.512E-01,8.706E-01,1,MHC class II,
944,Neuroendocrine transdifferentiation in Prostate Cancer,48,7.512E-01,8.706E-01,7.512E-01,8.706E-01,1,STAT3,
945,Muscle contraction_Relaxin signaling pathway,48,7.512E-01,8.706E-01,7.512E-01,8.706E-01,1,Adenylate cyclase type V,
946,"Nicotine signaling in dopaminergic neurons, Pt. 1 - cell body",48,7.512E-01,8.706E-01,7.512E-01,8.706E-01,1,nAChR alpha-4,
947,GLP-1 in beta cell apoptosis in type 2 diabetes,48,7.512E-01,8.706E-01,7.512E-01,8.706E-01,1,Bcl-2,
948,Bile Acid Biosynthesis,94,7.533E-01,8.706E-01,7.533E-01,8.706E-01,2,"AKR1C4, ACOX2",
949,Development_Melanocyte development and pigmentation,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,PAX3,
950,Activation of TNF-alpha-dependent pro-tumoral effect in colorectal cancer,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,p38 MAPK,
951,Role and regulation of Prostaglandin E2 in gastric cancer,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,Adenylate cyclase,
952,Breakdown of CD4+ T cell peripheral tolerance in type 1 diabetes mellitus,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,MHC class II,
953,Demyelination in multiple sclerosis,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,p38 MAPK,
954,Axonal degeneration in multiple sclerosis,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,CACNA1D,
955,Cytoskeleton remodeling_Integrin outside-in signaling,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,Collagen II,
956,Tissue Factor signaling in cancer via PAR1 and PAR2,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,Coagulation factor VII,
957,Transcription_CREB signaling pathway,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,p38 MAPK,
958,Development_PEDF signaling,49,7.583E-01,8.706E-01,7.583E-01,8.706E-01,1,Bcl-2,
959,Immune response_Production and main functions of biologically active leukotrienes and Lipoxin A4,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,ABCC11,
960,Suppression of p53 signaling in multiple myeloma,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,Bcl-2,
961,TGF-beta signaling via microRNA in breast cancer,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,Bcl-2,
962,Immune response_Lectin induced complement pathway,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,Clusterin,
963,Pro-inflammatory action of Gastrin in gastric cancer,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,p38alpha (MAPK14),
964,Immune response_Function of MEF2 in T lymphocytes,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,p38alpha (MAPK14),
965,VEGF signaling in multiple myeloma,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,STAT3,
966,L-Threonine metabolism,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,SLC7A8,
967,IgE- and MGF-induced Lyn-mediated production of cytokines and arachidonic acid metabolites in lung mast cells in asthma,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,p38 MAPK,
968,HBV-dependent NF-kB and PI3K/AKT pathways leading to HCC,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,Androgen receptor,
969,Immune response_IL-13 signaling via PI3K-ERK pathway,50,7.652E-01,8.706E-01,7.652E-01,8.706E-01,1,Mucin 5AC,
970,Immune response_TCR alpha/beta signaling pathway,97,7.686E-01,8.706E-01,7.686E-01,8.706E-01,2,"p38alpha (MAPK14), MHC class II",
971,Cortisone biosynthesis and metabolism,51,7.719E-01,8.706E-01,7.719E-01,8.706E-01,1,AKR1C4,
972,Neurophysiological process_GABAergic neurotransmission,51,7.719E-01,8.706E-01,7.719E-01,8.706E-01,1,GABT,
973,HIF-1 in gastric cancer,51,7.719E-01,8.706E-01,7.719E-01,8.706E-01,1,Bcl-2,
974,PI3K signaling in gastric cancer,51,7.719E-01,8.706E-01,7.719E-01,8.706E-01,1,IL8RB,
975,Immune response_IFN-gamma signaling via MAPK,51,7.719E-01,8.706E-01,7.719E-01,8.706E-01,1,p38 MAPK,
976,Immune response_BAFF-induced signaling,51,7.719E-01,8.706E-01,7.719E-01,8.706E-01,1,p38 MAPK,
977,Inhibition of Calcitriol/ VDR signaling in colorectal cancer,51,7.719E-01,8.706E-01,7.719E-01,8.706E-01,1,Cystatin D,
978,Immune response_NF-AT in immune response,51,7.719E-01,8.706E-01,7.719E-01,8.706E-01,1,MHC class II,
979,Development_TGF-beta receptor signaling,52,7.785E-01,8.708E-01,7.785E-01,8.708E-01,1,p38 MAPK,
980,Signal transduction_Additional pathways of NF-kB activation (in the cytoplasm),52,7.785E-01,8.708E-01,7.785E-01,8.708E-01,1,Adenylate cyclase,
981,G-protein signaling_Proinsulin C-peptide signaling,52,7.785E-01,8.708E-01,7.785E-01,8.708E-01,1,Bcl-2,
982,CoA biosynthesis,52,7.785E-01,8.708E-01,7.785E-01,8.708E-01,1,ENPP1,
983,Signal transduction_Activation of PKC via G-Protein coupled receptor,52,7.785E-01,8.708E-01,7.785E-01,8.708E-01,1,MLCK,
984,Glucagon-induced glucose upregulation in type 2 diabetes in liver ,52,7.785E-01,8.708E-01,7.785E-01,8.708E-01,1,Adenylate cyclase,
985,Neurophysiological process_Synaptic vesicle fusion and recycling in nerve terminals,52,7.785E-01,8.708E-01,7.785E-01,8.708E-01,1,Amphiphysin I,
986,Alcohol metabolism predisposition of HCC development,52,7.785E-01,8.708E-01,7.785E-01,8.708E-01,1,ADH7,
987,Apoptosis and survival_Role of PKR in stress-induced apoptosis,53,7.848E-01,8.717E-01,7.848E-01,8.717E-01,1,PP2A regulatory,
988,Immune response_Classical complement pathway,53,7.848E-01,8.717E-01,7.848E-01,8.717E-01,1,Clusterin,
989,ENaC regulation in normal and CF airways ,53,7.848E-01,8.717E-01,7.848E-01,8.717E-01,1,Adenylate cyclase,
990,Regulation of VEGF expression in lung cancer,53,7.848E-01,8.717E-01,7.848E-01,8.717E-01,1,STAT3,
991,TLRs-mediated IFN-alpha production by plasmacytoid dendritic cells in SLE,53,7.848E-01,8.717E-01,7.848E-01,8.717E-01,1,CAMP,
992,Immune response_Induction of the antigen presentation machinery by IFN-gamma,53,7.848E-01,8.717E-01,7.848E-01,8.717E-01,1,MHC class II,
993,Immune response_Antiviral actions of Interferons,53,7.848E-01,8.717E-01,7.848E-01,8.717E-01,1,MHC class II,
994,Immune response_IFN-gamma signaling via JAK/STAT and PLC-gamma,54,7.910E-01,8.729E-01,7.910E-01,8.729E-01,1,STAT3,
995,Androstenedione and testosterone biosynthesis and metabolism p.1,54,7.910E-01,8.729E-01,7.910E-01,8.729E-01,1,HSD17B1,
996,Blood coagulation_GPVI-dependent platelet activation,54,7.910E-01,8.729E-01,7.910E-01,8.729E-01,1,Glycoprotein VI,
997,Ganglioside Metabolism p1,54,7.910E-01,8.729E-01,7.910E-01,8.729E-01,1,GM3 synthase,
998,Translation_Regulation of EIF4F activity,54,7.910E-01,8.729E-01,7.910E-01,8.729E-01,1,p38 MAPK,
999,NRF2 regulation of oxidative stress response,54,7.910E-01,8.729E-01,7.910E-01,8.729E-01,1,GSTA3,
1000,Heme metabolism,103,7.968E-01,8.729E-01,7.968E-01,8.729E-01,2,"UGT2B28, UGT2B17",
1001,Chemotaxis_CCL2-induced chemotaxis,55,7.970E-01,8.729E-01,7.970E-01,8.729E-01,1,p38 MAPK,
1002,Aberrant B-Raf signaling in melanoma progression,55,7.970E-01,8.729E-01,7.970E-01,8.729E-01,1,Bcl-2,
1003,Immune response_IL-16 signaling pathway,55,7.970E-01,8.729E-01,7.970E-01,8.729E-01,1,CCR5,
1004,Immune response_CD28 signaling,55,7.970E-01,8.729E-01,7.970E-01,8.729E-01,1,p38 MAPK,
1005,Immune response_Role of DAP12 receptors in NK cells,55,7.970E-01,8.729E-01,7.970E-01,8.729E-01,1,KIR2DL4,
1006,Oxidative stress_Role of ASK1 under oxidative stress,55,7.970E-01,8.729E-01,7.970E-01,8.729E-01,1,p38 MAPK,
1007,Immune response_Immunological synapse formation,55,7.970E-01,8.729E-01,7.970E-01,8.729E-01,1,MHC class II,
1008,Role of FSH and Lutropin in ovarian cancer,56,8.028E-01,8.751E-01,8.028E-01,8.751E-01,1,Adenylate cyclase,
1009,Muscle contraction_ACM regulation of smooth muscle contraction,56,8.028E-01,8.751E-01,8.028E-01,8.751E-01,1,MLCK,
1010,Muscle contraction_Regulation of eNOS activity in cardiomyocytes,56,8.028E-01,8.751E-01,8.028E-01,8.751E-01,1,Adenylate cyclase type V,
1011,Cytoskeleton remodeling_FAK signaling,57,8.084E-01,8.751E-01,8.084E-01,8.751E-01,1,GRP-R,
1012,Proinflammatory mediators release and arachidonic acid metabolites production in basophils in asthma,57,8.084E-01,8.751E-01,8.084E-01,8.751E-01,1,p38 MAPK,
1013,Ca(2+)-dependent NF-AT signaling in cardiac hypertrophy,57,8.084E-01,8.751E-01,8.084E-01,8.751E-01,1,Adenylate cyclase type V,
1014,Development_Non-genomic action of Retinoic acid in cell differentiation,57,8.084E-01,8.751E-01,8.084E-01,8.751E-01,1,Rb protein,
1015,Immune response_Role of PKR in stress-induced antiviral cell response,57,8.084E-01,8.751E-01,8.084E-01,8.751E-01,1,p38alpha (MAPK14),
1016,Gamma-Secretase regulation of neuronal cell development and function,57,8.084E-01,8.751E-01,8.084E-01,8.751E-01,1,Tau (MAPT),
1017,Prostaglandin 1 biosynthesis and metabolism,57,8.084E-01,8.751E-01,8.084E-01,8.751E-01,1,ALOX15B,
1018,CCR7 signaling pathways in dendritic cells in allergic contact dermatitis,57,8.084E-01,8.751E-01,8.084E-01,8.751E-01,1,p38 MAPK,
1019,Signal transduction_Angiotensin II signaling via Beta-arrestin,57,8.084E-01,8.751E-01,8.084E-01,8.751E-01,1,MLCK,
1020,Cell adhesion_Integrin inside-out signaling,58,8.139E-01,8.752E-01,8.139E-01,8.752E-01,1,Collagen II,
1021,Aberrant production of IL-2 and IL-17 in SLE T cells,58,8.139E-01,8.752E-01,8.139E-01,8.752E-01,1,MHC class II,
1022,Immune response_IL-33 signaling pathway,58,8.139E-01,8.752E-01,8.139E-01,8.752E-01,1,p38alpha (MAPK14),
1023,Effect of H. pylori infection on gastric epithelial cell proliferation,58,8.139E-01,8.752E-01,8.139E-01,8.752E-01,1,p38alpha (MAPK14),
1024,Oxidative stress_ROS-induced cellular signaling,108,8.179E-01,8.752E-01,8.179E-01,8.752E-01,2,"p38alpha (MAPK14), p38 MAPK",
1025,Regulation of lipid metabolism_G-alpha(q) regulation of lipid metabolism,59,8.192E-01,8.752E-01,8.192E-01,8.752E-01,1,ABCG1,
1026,Neurophysiological process_Constitutive and activity-dependent synaptic AMPA receptor delivery,59,8.192E-01,8.752E-01,8.192E-01,8.752E-01,1,Chapsyn-110,
1027,Signal transduction_Production and main functions of biologically active prostaglandins and Thromboxane A2,59,8.192E-01,8.752E-01,8.192E-01,8.752E-01,1,PGE2R3,
1028,A shift from oxidative to glycolytic muscle fiber phenotype in quadriceps muscles in COPD,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,Fatty acid-binding protein,
1029,EGFR signaling pathway in colorectal cancer,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,Amphiregulin,
1030,Immune response_ICOS signaling pathway in T-helper cell,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,MHC class II,
1031,Oxidative stress_Role of Sirtuin1 and PGC1-alpha in activation of antioxidant defense system,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,GSTM5,
1032,Immune response_LTBR1 signaling,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,Adenylate cyclase,
1033,Neutrophil resistance to apoptosis in COPD and proresolving impact of lipid mediators,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,p38 MAPK,
1034,Aberrant lipid trafficking and metabolism in age-related macular degeneration pathogenesis,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,Clusterin,
1035,Stimulation of gastric acid secretion in gastric cancer,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,Adenylate cyclase,
1036,Antioxidant effects of statins in COPD,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,RhoB,
1037,Triacylglycerol metabolism p.1,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,AKR1C4,
1038,Transcription_Effect of Folic acid on genome stability,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,FR-beta,
1039,Immune response_TREM1 signaling pathway,60,8.244E-01,8.752E-01,8.244E-01,8.752E-01,1,TREM1,
1040,Immune response_B cell antigen receptor (BCR) pathway,110,8.257E-01,8.758E-01,8.257E-01,8.758E-01,2,"Rb protein, p38 MAPK",
1041,Development_c-Kit ligand signaling pathway during hemopoiesis,61,8.294E-01,8.772E-01,8.294E-01,8.772E-01,1,STAT3,
1042,Effect of H. pylori infection on inflammation in gastric epithelial cells,61,8.294E-01,8.772E-01,8.294E-01,8.772E-01,1,p38alpha (MAPK14),
1043,Induction of mucin secretion in  airway goblet cells by purinergic receptors,61,8.294E-01,8.772E-01,8.294E-01,8.772E-01,1,PP2A regulatory,
1044,Aminoglycoside- and cisplatin-induced hair cell death,112,8.333E-01,8.773E-01,8.333E-01,8.773E-01,2,"p38 MAPK, Bcl-2",
1045,Development_Negative regulation of STK3/4 (Hippo) pathway and positive regulation of YAP/TAZ function,62,8.343E-01,8.773E-01,8.343E-01,8.773E-01,1,YAP1 (YAp65),
1046,Renin-Angiotensin-Aldosterone System,62,8.343E-01,8.773E-01,8.343E-01,8.773E-01,1,p38alpha (MAPK14),
1047,Regulation of microRNAs in colorectal cancer,62,8.343E-01,8.773E-01,8.343E-01,8.773E-01,1,STAT3,
1048,Development_WNT/Beta-catenin signaling in the nucleus,62,8.343E-01,8.773E-01,8.343E-01,8.773E-01,1,p38 MAPK,
1049,Development_Alpha-2 adrenergic receptor activation of ERK,62,8.343E-01,8.773E-01,8.343E-01,8.773E-01,1,Alpha-2A adrenergic receptor,
1050,Propionate metabolism p.2,63,8.391E-01,8.806E-01,8.391E-01,8.806E-01,1,GABT,
1051,Vascular endothelial cell damage in SLE,63,8.391E-01,8.806E-01,8.391E-01,8.806E-01,1,p38 MAPK,
1052,CHDI_Correlations from Replication data_Cytoskeleton and adhesion module,64,8.437E-01,8.812E-01,8.437E-01,8.812E-01,1,MHC class II,
1053,TGF-beta-induced fibroblast/ myofibroblast migration and extracellular matrix production in asthmatic airways,64,8.437E-01,8.812E-01,8.437E-01,8.812E-01,1,p38 MAPK,
1054,Plasmalogen biosynthesis,64,8.437E-01,8.812E-01,8.437E-01,8.812E-01,1,PLA2,
1055,Development_Positive regulation of WNT/Beta-catenin signaling at the receptor level,64,8.437E-01,8.812E-01,8.437E-01,8.812E-01,1,p38alpha (MAPK14),
1056,Polyamine metabolism,64,8.437E-01,8.812E-01,8.437E-01,8.812E-01,1,ABP1,
1057,Signal transduction_mTORC2 upstream signaling,65,8.482E-01,8.834E-01,8.482E-01,8.834E-01,1,DEPTOR,
1058,Unsaturated fatty acid biosynthesis,65,8.482E-01,8.834E-01,8.482E-01,8.834E-01,1,ELOVL2,
1059,Signal transduction_PDGF signaling via MAPK cascades,65,8.482E-01,8.834E-01,8.482E-01,8.834E-01,1,p38 MAPK,
1060,Pyruvate metabolism,66,8.525E-01,8.846E-01,8.525E-01,8.846E-01,1,LDHD,
1061,Canonical WNT signaling pathway in colorectal cancer,66,8.525E-01,8.846E-01,8.525E-01,8.846E-01,1,Mucin 2,
1062,Immune response_T regulatory cell-mediated modulation of antigen-presenting cell functions,66,8.525E-01,8.846E-01,8.525E-01,8.846E-01,1,MHC class II,
1063,Metabolism in pancreatic cancer cells,66,8.525E-01,8.846E-01,8.525E-01,8.846E-01,1,DHE4,
1064,"Metabolism of L-cysteine, D-cysteine and L-cystine",119,8.575E-01,8.890E-01,8.575E-01,8.890E-01,2,"SLC7A8, SLC1A2/EAAT2",
1065,Immune response_Sublytic effects of membrane attack complex,68,8.609E-01,8.891E-01,8.609E-01,8.891E-01,1,p38 MAPK,
1066,Immune response_Gastrin in inflammatory response,68,8.609E-01,8.891E-01,8.609E-01,8.891E-01,1,p38alpha (MAPK14),
1067,Eosinophil adhesion and transendothelial migration in asthma,68,8.609E-01,8.891E-01,8.609E-01,8.891E-01,1,p38 MAPK,
1068,Lipoprotein metabolism,68,8.609E-01,8.891E-01,8.609E-01,8.891E-01,1,ABCG1,
1069,Immune response_CD16 signaling in NK cells,69,8.648E-01,8.899E-01,8.648E-01,8.899E-01,1,PLA2,
1070,Transcription_Negative regulation of HIF1A function,69,8.648E-01,8.899E-01,8.648E-01,8.899E-01,1,MTG16 (CBFA2T3),
1071,Immune response_OX40L/ OX40 signaling pathway,69,8.648E-01,8.899E-01,8.648E-01,8.899E-01,1,Bcl-2,
1072,Development_Positive regulation of WNT/Beta-catenin signaling in the nucleus,69,8.648E-01,8.899E-01,8.648E-01,8.899E-01,1,YAP1 (YAp65),
1073,Signal transduction_PDGF signaling via PI3K/AKT and NFkB pathways,70,8.687E-01,8.922E-01,8.687E-01,8.922E-01,1,YB-1,
1074,Mechanisms of drug resistance in SCLC,70,8.687E-01,8.922E-01,8.687E-01,8.922E-01,1,Bcl-2,
1075,Transport_Clathrin-coated vesicle cycle,71,8.725E-01,8.952E-01,8.725E-01,8.952E-01,1,Myosin I,
1076,Mitochondrial beta-oxidation of long-chain saturated fatty acids,125,8.757E-01,8.965E-01,8.757E-01,8.965E-01,2,"A-FABP, B-FABP",
1077,Regulation of lipid metabolism_Stimulation of Arachidonic acid production by ACM receptors,72,8.761E-01,8.965E-01,8.761E-01,8.965E-01,1,p38 MAPK,
1078,Neolacto-series GSL Metabolism p.1,72,8.761E-01,8.965E-01,8.761E-01,8.965E-01,1,FUT6,
1079,Immune response_Distinct metabolic pathways in naive and effector CD8+ T cells,74,8.831E-01,8.995E-01,8.831E-01,8.995E-01,1,DHE4,
1080,Metabolism of L-Proline and derivatives,74,8.831E-01,8.995E-01,8.831E-01,8.995E-01,1,CRYM,
1081,Arachidonic acid production,74,8.831E-01,8.995E-01,8.831E-01,8.995E-01,1,PLA2G2D,
1082,Peroxysomal straight-chain fatty acid beta-oxidation,74,8.831E-01,8.995E-01,8.831E-01,8.995E-01,1,ACOX2,
1083,Ubiquinone metabolism,74,8.831E-01,8.995E-01,8.831E-01,8.995E-01,1,TAT,
1084,Development_Positive regulation of WNT/Beta-catenin signaling in the cytoplasm,76,8.898E-01,9.053E-01,8.898E-01,9.053E-01,1,YAP1 (YAp65),
1085,Role of activation of WNT signaling in the progression of lung cancer,77,8.929E-01,9.077E-01,8.929E-01,9.077E-01,1,p38 MAPK,
1086,Signal transduction_Angiotensin II/ AGTR1 signaling via RhoA and JNK,78,8.960E-01,9.100E-01,8.960E-01,9.100E-01,1,MLCK,
1087,Chemotaxis_SDF-1/ CXCR4-induced chemotaxis of immune cells,79,8.990E-01,9.122E-01,8.990E-01,9.122E-01,1,SFK,
1088,Vitamin E (alfa-tocopherol) metabolism,81,9.047E-01,9.172E-01,9.047E-01,9.172E-01,1,ACOX2,
1089,HETE and HPETE biosynthesis and metabolism,82,9.074E-01,9.191E-01,9.074E-01,9.191E-01,1,ALOX15B,
1090,Transport_Intracellular cholesterol transport,83,9.101E-01,9.201E-01,9.101E-01,9.201E-01,1,ABCG1,
1091,Cytoskeleton remodeling_PDGF signaling via calcium and Rho GTPases,83,9.101E-01,9.201E-01,9.101E-01,9.201E-01,1,EBP50,
1092,Peroxisomal branched chain fatty acid oxidation,84,9.127E-01,9.210E-01,9.127E-01,9.210E-01,1,ACOX2,
1093,SLE genetic marker-specific pathways in antigen-presenting cells (APC),84,9.127E-01,9.210E-01,9.127E-01,9.210E-01,1,Fc gamma RIII beta,
1094,Prostaglandin 2 biosynthesis and metabolism,86,9.176E-01,9.252E-01,9.176E-01,9.252E-01,1,LOXE3,
1095,Immune response_Fc epsilon RI pathway: Lyn-mediated cytokine production,87,9.200E-01,9.267E-01,9.200E-01,9.267E-01,1,p38 MAPK,
1096,Regulation of lipid metabolism_Insulin regulation of fatty acid metabolism,89,9.245E-01,9.296E-01,9.245E-01,9.296E-01,1,Perilipin,
1097,Immune response_The effect of IDO1 on T cell metabolism,89,9.245E-01,9.296E-01,9.245E-01,9.296E-01,1,DHE4,
1098,Glycolysis and gluconeogenesis,94,9.347E-01,9.390E-01,9.347E-01,9.390E-01,1,F16P,
1099,"Signal transduction_Angiotensin II/ AGTR1 signaling via p38, ERK and PI3K",98,9.419E-01,9.454E-01,9.419E-01,9.454E-01,1,p38 MAPK,
1100,Immune response_Antigen presentation by MHC class I: cross-presentation,99,9.436E-01,9.462E-01,9.436E-01,9.462E-01,1,CLEC12A,
1101,Immune response_IL-3 signaling via ERK and PI3K,102,9.483E-01,9.500E-01,9.483E-01,9.500E-01,1,Bcl-2,
1102,CTP/UTP metabolism,107,9.553E-01,9.562E-01,9.553E-01,9.562E-01,1,AID,
1103,Vitamin B3 and NAD+ metabolism,125,9.736E-01,9.736E-01,9.736E-01,9.736E-01,1,ENPP1,
,,,,,,,,,
